( (TITLE (NP (NP (JJ Additive) (NNS Effects)) (PP (IN of) (NP (NML (NN PDGF) (NN Receptor) (NN β)) (NN Signaling) (NNS Pathways))) (PP (IN in) (NP (NML (JJ Vascular) (NML (JJ Smooth) (NN Muscle)) (NN Cell)) (NN Development))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ-1 (DT The) (NML (NML (NML (ADJP (NN platelet) (HYPH -) (VBN derived)) (NN growth) (NN factor) (NN β)) (NN receptor)) (-LRB- -LRB-) (NML (NN PDGFRβ)))) (-RRB- -RRB-) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (VP (TO to) (VP (VB activate) (NP (NP (JJ many) (NNS molecules)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN signal) (NN transduction))))))) (CC and) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT a) (NN paradigm)) (PP (IN for) (NP (NML (NN receptor) (NN tyrosine) (NN kinase)) (NN signaling)))) (PP-TMP (IN for) (NP (JJ many) (NNS years))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBP have) (VP (VBN sought) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (JJ individual) (NN signaling) (NNS components)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT this) (NN receptor))))))) (ADJP-LOC (FW in) (FW vivo))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG analyzing) (NP (NP (NP (DT an) (JJ allelic) (NN series)) (PP (IN of) (NP (NML (NN tyrosine) (HYPH –) (NN phenylalanine)) (NNS mutations)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP prevent) (NP (NP (NN binding)) (PP (IN of) (NP (JJ specific) (NML (NN signal) (NN transduction)) (NNS components)))))))))))))))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NP (NP (NML (JJ vascular) (JJ smooth) (NN muscle)) (NNS cells)) (HYPH /) (NP (NNS pericytes))) (-LRB- -LRB-) (NP (NN v) (HYPH /) (NN p)) (-RRB- -RRB-)) (, ,) (NP (DT a) (ADJP (NN PDGFRβ) (HYPH -) (JJ dependent)) (NN cell) (NN type))))) (, ,) (VP (MD can) (VP (VB be) (VP (VBN correlated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN receptor)) (VP (VBN expressed) (NP (-NONE- *)))))) (CC and) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ activated) (NML (NN signal) (NN transduction)) (NNS pathways)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN decrease)) (PP (IN in) (NP (CC either) (NP (NN receptor) (NN expression) (NNS levels)) (CC or) (NP (NP (NN disruption)) (PP (IN of) (NP (JJ multiple) (JJ downstream) (NN signaling) (NNS pathways))))))) (VP (VBP lead) (PP (IN to) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NN v) (HYPH /) (NN p)))))) (. .)) )
( (S (ADVP (RB Conversely)) (, ,) (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NN RasGAP) (NN binding)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (DT this) (JJ same) (NN cell) (NN population))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG implicating) (NP (NP (DT a) (JJ potential) (NN role)) (PP (IN for) (NP (DT this) (NN effector))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG attenuating) (NP (DT the) (NN PDGFRβ) (NN signal))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ combined) (ADJP (ADJP (FW in) (FW vivo)) (CC and) (ADJP (JJ biochemical))) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN summation)) (PP (IN of) (NP (NP (NNS pathways)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (NN PDGFRβ) (NN signal) (NN transduction))))))) (VP (VBZ determines) (NP (NP (DT the) (NN expansion)) (PP (IN of) (NP (VBG developing) (NML (NN v) (HYPH /) (NN p)) (NNS cells)))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (NN signal) (NN transduction)) (PP (IN by) (NP (NP (NN receptor) (NN tyrosine) (NNS kinases)) (-LRB- -LRB-) (NP (NNS RTKs))))) (-RRB- -RRB-) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (NP-1 (-NONE- *)) (ADVP (RB extensively))))))) (, ,) (NP-SBJ (NP (DT the) (NNS roles)) (PP (IN of) (NP (NP (JJ individual) (NN signaling) (NN proteins)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT these) (NNS receptors))))))) (VP (VBP are) (NP-PRD (NP (DT a) (NN matter)) (PP (IN of) (NP (NN debate))))) (. .)) )
( (S (NP-SBJ (DT Some) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (NN disruption)) (PP (IN of) (NP (JJ particular) (NNS pathways)))) (VP (VBZ leads) (PP (IN to) (NP (NP (NN loss)) (PP (IN of) (NP (JJ specific) (JJ cellular) (NNS functions)))))))) (CIT (-LRB- -LRB-) (NNP Valius) (CC and) (NNP Kazlauskas) (CD 1993) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NNS Others)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S-CLF (NP-SBJ (PRP it)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN sum)) (PP (IN of) (NP (DT the) (NNS signals)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (JJ unique) (JJ cellular) (NNS outcomes)) (VP (VBN directed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT each) (NN receptor)))))))))))) (CIT (-LRB- -LRB-) (NNP Fambrough) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))) (. .)) )
( (S (CC Yet) (NP-SBJ (NNS others)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NN interpretation)) (PP (IN of) (NP (NN receptor) (NNS signals)))) (VP (VBZ is) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (JJ distinct) (JJ cellular) (NN history))))))) (CIT (-LRB- -LRB-) (NNP Flores) (FW et) (FW al.) (CD 2000) (: ;) (NNP Halfon) (FW et) (FW al.) (CD 2000) (: ;) (NNP Xu) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-1 (NP (JJ many)) (PP (IN of) (NP (DT these) (NNS conclusions)))) (VP (VBP have) (VP (VBN been) (VP (VBN reached) (NP-1 (-NONE- *)) (PP (PP-LOC (IN in) (NP (JJ diverse) (NN cell) (NNS types))) (CC and) (PP-MNR (IN through) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (JJ different) (NNS RTKs))))))))))) (, ,) (NP-SBJ (NP (PRP it)) (S-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ difficult)) (S-2 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ-3 (NP (NNS results)) (PP (IN from) (NP (CD one) (NN receptor) (NN system)))) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-3 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generalize) (NP (NP (DT the) (NNS functions)) (PP (IN of) (NP (NN RTK) (NN signaling)))))))))))))))) (. .)) )
( (S (ADVP-TMP (RB Recently)) (, ,) (NP-SBJ (JJ several) (NNS labs)) (VP (VBP have) (VP (VBN dissected) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (NN RTK) (JJ modular) (NN signaling) (NNS components)))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG generating) (NP (NN point) (NNS mutations)) (PP-LOC (IN in) (NP (NP (JJ cytoplasmic) (NNS domains)) (PP (IN of) (NP (NP (DT the) (NNS receptors)) (PP-LOC (IN in) (NP (NNS mice)))))))))) (CIT (-LRB- -LRB-) (NNP Partanen) (FW et) (FW al.) (CD 1998) (: ;) (NNP Heuchel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Blume) (HYPH -) (NNP Jensen) (FW et) (FW al.) (CD 2000) (: ;) (NNP Kissel) (FW et) (FW al.) (CD 2000) (: ;) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (: ;) (NNP Klinghoffer) (FW et) (FW al.) (CD 2001) (, ,) (CD 2002) (: ;) (NNP Maina) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS studies)) (VP (VBP have) (VP (VBN revealed) (NP (NP (DT a) (JJ unique) (NN requirement)) (PP (IN for) (NP (JJ individual) (NN signaling) (NNS components)))) (PP-LOC (IN in) (NP (JJ specific) (NN cell) (NNS types))) (CIT (-LRB- -LRB-) (NNP Partanen) (FW et) (FW al.) (CD 1998) (: ;) (NNP Blume) (HYPH -) (NNP Jensen) (FW et) (FW al.) (CD 2000) (: ;) (NNP Kissel) (FW et) (FW al.) (CD 2000) (: ;) (NNP Maina) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (JJ similar) (NNS experiments)) (PP (IN on) (NP (NML (NML (ADJP (NN platelet) (HYPH -) (VBN derived)) (NML (NN growth) (NN factor)) (NN receptor) (NN α)) (-LRB- -LRB-) (NML (NN PDGFRα))) (-RRB- -RRB-) (NN signaling) (NNS mutants)))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NML (NML (NML (NML (NN phosphatidylinositol) (NML (CD 3) (SYM ′))) (HYPH -) (NN kinase)) (-LRB- -LRB-) (NML (NN PI3K))) (-RRB- -RRB-) (CC and) (NML (NML (NN Src) (NN family) (NN kinase)) (-LRB- -LRB-) (NML (NN SFK)))) (-RRB- -RRB-) (NML (NN signal) (NN transduction)) (NNS pathways)) (VP (VBP play) (NP (NNS roles)) (PP (IN in) (NP (NN oligodendrocyte) (NN development)))))) (CIT (-LRB- -LRB-) (NNP Klinghoffer) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS experiments)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NNS requirements)) (PP (IN for) (NP (NN signal) (NN transduction)))) (VP (VBP vary) (PP-MNR (CONJP (RB not) (RB only)) (PP (IN by) (NP (NP (DT the) (NN receptor)) (PP (IN under) (NP (NN consideration))))) (, ,) (CONJP (CC but) (RB also)) (PP (IN by) (NP (NP (DT the) (NN cell) (NN lineage)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBG receiving) (NP (DT the) (NN signal))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NML (ADJP (NN platelet) (HYPH -) (VBN derived)) (NML (NN growth) (NN factor)) (NN receptor) (NN β)) (-LRB- -LRB-) (NML (NN PDGFRβ)))) (-RRB- -RRB-) (VP (VP (VBZ has) (CONJP (RB not) (RB only)) (VP (VBN been) (VP (VBN studied) (NP-1 (-NONE- *)) (ADVP (RB physiologically))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT the) (NN focus)) (PP (IN of) (NP (JJ intensive) (JJ biochemical) (NN analysis))))))) (. .)) )
( (S (PP (IN Upon) (NP (NN ligand) (NN binding))) (, ,) (NP-SBJ-1 (DT the) (NN PDGFRβ)) (VP (VP (VBZ dimerizes)) (CC and) (VP (VBZ is) (VP (VBN autophosphorylated) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (QP (RB as) (JJ many) (IN as) (CD 13)) (NML (JJ cytoplasmic) (NN tyrosine)) (NNS residues)))))) (. .)) )
( (S (NP-SBJ (DT These) (VBN phosphorylated) (NNS tyrosines)) (VP (VBP become) (NP-PRD (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (NN SH2) (ADJP (NN domain) (HYPH -) (VBG containing)) (NN proteins)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP initiate) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NML (NN signal) (NN transduction)) (NNS pathways)))))))))) (CIT (-LRB- -LRB-) (VBN reviewed) (IN by) (NNP Claesson) (HYPH -) (NNP Welsh) (CD 1994) (: ;) (NNP Heldin) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS pathways)) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN PDGFRβ))))) (VP (VBP control) (NP (NP (JJ multiple) (JJ cellular) (NNS functions)) (, ,) (PP (VBG including) (NP (NP (NN proliferation)) (, ,) (NP (NN migration)) (, ,) (NP (NN matrix) (NN deposition)) (, ,) (CC and) (NP (JJ immediate) (JJ early) (NN gene) (NN induction))))) (CIT (-LRB- -LRB-) (VBN reviewed) (IN by) (NNP Heldin) (CC and) (NNP Westermark) (CD 1999) (: ;) (NNP Betsholtz) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (QP (RB At) (RBS least) (CD ten)) (JJ distinct) (ADJP (NP (NN SH2) (NN domain)) (HYPH -) (VBG containing)) (NN proteins)) (VP (MD can) (VP (VP (VB bind) (NP (DT the) (VBN phosphorylated) (NN PDGFRβ))) (CC and) (VP (VBP activate) (NP (JJ downstream) (NML (NN signal) (NN transduction)) (NNS cascades))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS molecules)) (VP (VBP include) (NP (NP (NN SFK) (CIT (-LRB- -LRB-) (NNP Kypta) (FW et) (FW al.) (CD 1990) (-RRB- -RRB-))) (, ,) (NP (NN PI3K) (CIT (-LRB- -LRB-) (NNP Kazlauskas) (CC and) (NNP Cooper) (CD 1990) (: ;) (NNP Kundra) (FW et) (FW al.) (CD 1994) (: ;) (NNP Wennstrom) (FW et) (FW al.) (CD 1994a) (, ,) (CD 1994b) (-RRB- -RRB-))) (, ,) (NP (NN Shc) (CIT (-LRB- -LRB-) (NNP Yokote) (FW et) (FW al.) (CD 1994) (-RRB- -RRB-))) (, ,) (NP (NN RasGAP) (CIT (-LRB- -LRB-) (NNP Kaplan) (FW et) (FW al.) (CD 1990) (: ;) (NNP Kazlauskas) (FW et) (FW al.) (CD 1990) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN signal) (NNS transducers)) (CC and) (NP (NP (NNS activators)) (PP (IN of) (NP (NN transcription))))) (-LRB- -LRB-) (NP (NNS STATs)) (-RRB- -RRB-) (CIT (-LRB- -LRB-) (NNP Vignais) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))) (, ,) (NP (NN Grb2) (CIT (-LRB- -LRB-) (NNP Arvidsson) (FW et) (FW al.) (CD 1994) (-RRB- -RRB-))) (, ,) (NP (NN Grb7) (CIT (-LRB- -LRB-) (NNP Yokote) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NML (NN SH2) (HYPH -) (VBG containing)) (NN phosphotyrosine) (NN phosphatase)) (-LRB- -LRB-) (NP (NN SHP) (HYPH -) (CD 2))) (, ,) (VP (ADVP (RB also)) (VBN known) (NP (-NONE- *)) (PP-MNR (IN as) (NP (NN SH) (HYPH -) (NN PTP2)))) (-RRB- -RRB-) (CIT (-LRB- -LRB-) (NNP Kazlauskas) (FW et) (FW al.) (CD 1993) (: ;) (NNP Lechleider) (FW et) (FW al.) (CD 1993) (-RRB- -RRB-))) (, ,) (NP (NP (NN phospholipase) (NN Cγ)) (-LRB- -LRB-) (NP (NN PLCγ)) (-RRB- -RRB-) (CIT (-LRB- -LRB-) (NNP Meisenhelder) (FW et) (FW al.) (CD 1989) (: ;) (NNP Morrison) (FW et) (FW al.) (CD 1990) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN Nck) (CIT (-LRB- -LRB-) (NNP Nishimura) (FW et) (FW al.) (CD 1993) (-RRB- -RRB-))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (JJ multiple) (JJ downstream) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN attributed) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NN activation)) (PP (IN of) (NP (DT these) (NNS pathways)))))))))) (, ,) (NP-SBJ-2 (NP (PRP$ their) (JJ relative) (NN importance)) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN PDGFRβ))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN determined) (NP-2 (-NONE- *)) (ADVP-LOC (FW in) (FW vivo))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN concentrated) (NP (PRP$ our) (JJ present) (NNS analyses)) (PP (IN on) (NP (NP (NN signal) (NN transduction)) (PP (IN by) (NP (DT the) (NN PDGFRβ))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Previous) (NNS studies)) (VP (VBG using) (NP (NP (DT a) (JJ null) (NN allele)) (PP (IN of) (NP (DT the) (NN receptor)))))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (NN PDGFRβ) (NN signal) (NN transduction)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NP (NP (NML (JJ vascular) (JJ smooth) (NN muscle)) (NNS cells)) (CC and) (NP (NNS pericytes))) (-LRB- -LRB-) (NP (NN v) (HYPH /) (NN p)) (-RRB- -RRB-))))))))) (CIT (-LRB- -LRB-) (NNP Levéen) (FW et) (FW al.) (CD 1994) (: ;) (NNP Soriano) (CD 1994) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS cells)) (VP (VBP are) (NP-PRD (NP (DT the) (JJ mesenchymal) (NN support) (NNS cells)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP surround) (NP (NN blood) (NNS vessels)))))) (CIT (-LRB- -LRB-) (VBN reviewed) (IN by) (NNP Hungerford) (CC and) (NNP Little) (CD 1999) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Brain) (NNS pericytes)) (, ,) (NP (NN kidney) (JJ mesangial) (NNS cells)) (, ,) (NP (JJ retinal) (JJ mural) (NNS cells)) (, ,) (CC and) (NP (NML (NN limb) (CC and) (NN skin)) (NNS pericytes))) (VP (VBP have) (RB all) (VP (VBN been) (VP (VBN recognized) (NP-1 (-NONE- *)) (PP (IN as) (NP (NML (NN PDGFRβ) (HYPH -) (JJ dependent)) (NNS cells))) (CIT (-LRB- -LRB-) (NNP Lindahl) (FW et) (FW al.) (CD 1997a) (, ,) (CD 1998) (: ;) (NNP Hellström) (FW et) (FW al.) (CD 1999) (: ;) (NNP Enge) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NNS Studies)) (VP (VBP have) (VP (VBN indicated) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NN PDGFRβ)) (VP (VBZ is) (ADJP-PRD (JJ likely) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB play) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (NP (DT the) (NML (NN proliferation) (, ,) (NN migration))) (, ,) (CC or) (NP (DT both))) (PP (IN of) (NP (DT a) (NN progenitor) (NN population)))))))))))) (CIT (-LRB- -LRB-) (NNP Hellström) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP explain) (SBAR (WHADVP-1 (WRB why)) (S (NP-SBJ (JJ defective) (NN PDGF) (NN signal) (NN transduction)) (VP (VBZ results) (PP (PP (IN in) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN cell) (NN lineage))))) (CC and) (PP (ADVP (RB ultimately)) (IN in) (NP (JJ perinatal) (NN lethality)))) (PP-PRP (IN due) (IN to) (NP (NN vessel) (NN instability))) (ADVP-PRP-1 (-NONE- *T*))))) (CIT (-LRB- -LRB-) (NNP Hellström) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (NN PI3K) (CC and) (NN PLCγ)))) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN PDGFRβ))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN disrupted) (NP (PRP$ their) (VBG binding) (NNS sites)) (PP-LOC (IN in) (NP (NP (DT the) (NN receptor) (POS 's)) (JJ cytoplasmic) (NN domain))) (CIT (-LRB- -LRB-) (NNP Heuchel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Surprisingly)) (, ,) (S (S (NP-SBJ-1 (DT no) (JJ overt) (NNS phenotypes)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (JJ homozygous) (NNS mutants)) (VP (VBG lacking) (NP (DT these) (CD two) (NNS pathways)))))))) (, ,) (CC and) (S (NP-SBJ-2 (NNS deficiencies)) (VP (VBD were) (VP (VBN observed) (NP-2 (-NONE- *)) (SBAR-ADV (ADVP (RB only)) (WHADVP-4 (WRB when)) (S (NP-SBJ-3 (DT the) (NNS animals)) (VP (VBD were) (VP (VBN challenged) (NP-3 (-NONE- *)) (ADVP-MNR (RB physiologically)) (ADVP-TMP-4 (-NONE- *T*)))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (DT the) (VBG remaining) (NML (NN signal) (NN transduction)) (NNS pathways))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN created) (NP (DT a) (NN PDGFRβ) (JJ allelic) (NN series)) (PP-LOC (IN in) (NP (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP refer) (PP (IN to) (NP (DT this) (NN series))) (PP-MNR (IN as) (NP (DT the) (NN F) (NN series))) (SBAR-PRP (IN because) (S (NP-SBJ (PRP it)) (VP (VBZ contains) (NP (NML (NN Y) (HYPH –) (NN F)) (NNS mutations)) (PP-LOC (IN at) (NP (DT the) (JJ known) (NML (JJ phosphorylated) (NN tyrosine)) (NNS residues))))))) (. .)) )
( (S (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG Using) (NP (NML (NN v) (HYPH /) (NN p)) (NN cell) (NN number)) (PP-PRP (IN as) (NP (NP (DT a) (NN readout)) (PP (IN for) (NP (NN PDGFRβ) (NN signal) (NN transduction))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN determined) (SBAR (IN that) (S (NP-SBJ (NP (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN receptor)))) (VP (VBN expressed) (NP (-NONE- *)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NP (NN signaling) (NNS pathways)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN PDGFRβ)))))))) (VP (VBZ determines) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP form)))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP provide) (NP (NP (DT an) (NN example)) (PP (IN of) (S-NOM (NP-SBJ (NN RTK) (NN signal) (NN transduction)) (ADVP (RB quantitatively)) (VP (VBG controlling) (NP (JJ cellular) (NN development))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (DT the) (JJ Allelic) (NNS Series))))) )
( (S (S (NP-SBJ (NP (JJ Previous) (NNS studies)) (PP (IN of) (NP (DT the) (NN PDGFRβ)))) (VP (VBP have) (VP (VBN revealed) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN for) (NP (DT this) (NN receptor))) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NN development))))))) (, ,) (CC but) (S (NP-SBJ (VBZ attempts) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (JJ essential) (JJ biochemical) (NNS signals)))))) (ADVP-TMP (RB thus) (RB far)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (JJ certain) (NN signaling) (NNS pathways)))) (ADVP (RB only)) (VP (VBZ diminishes) (NP (ADJP (NN PDGFRβ) (HYPH -) (VBN driven)) (NNS responses))))) (CIT (-LRB- -LRB-) (NNP Heuchel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB study) (NP (JJ key) (NN signaling) (NNS pathways))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN generated) (NP (NP (DT an) (JJ allelic) (NN series)) (PP (IN of) (NP (NN PDGFRβ) (NNS mutants)))))) (. .)) )
( (S (NP-SBJ (NN Figure) (CD 1)) (VP (VBZ illustrates) (NP (NP (NP (DT the) (NNS mutations)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN generated) (NP-1 (-NONE- *T*)) (PP-LOC (IN in) (NP (DT the) (NN PDGFRβ) (NN locus)))))))) (CC and) (NP (NP (DT the) (NN signaling) (NNS pathways)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (VP (VBN disrupted) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (DT these) (NNS mutations)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT Each) (NN mutant)) (VP (MD will) (VP (VB be) (VP (VBN referred) (PP (IN to) (NP-1 (-NONE- *))) (PP-MNR (IN by) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS tyrosines)) (-LRB- -LRB-) (NP (NN Y)) (-RRB- -RRB-)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP have) (VP (VBN been) (VP (VBN mutated) (NP-2 (-NONE- *)))))))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (DT the) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site)))) (VP (VBZ is) (NP-PRD (DT the) (NML (NML (NN PDGFRβF1) (HYPH /) (NN F1)) (CC or) (NML (NN F1) (HYPH /) (NN F1))) (NN mutant))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN truncation) (NN mutation)) (PP (IN of) (NP (DT the) (NML (NML (NN PDGFRβ)) (-LRB- -LRB-) (NML (NN βT)))))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (NP (DT a) (NN frameshift)) (CC and) (NP (JJ subsequent) (JJ premature) (NN stop) (NN codon)))) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site)))))))) (. .)) )
( (S (NP-SBJ (NN Figure) (CD 2)) (VP (VBZ illustrates) (NP (NP (DT the) (VBG targeting) (NNS events)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NP (DT the) (NN series)) (PP (IN of) (NP (NNS mutants))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (ADJP (NP (NN F1) (HYPH -) (, ,) (NN F2) (HYPH -) (, ,) (NN F3) (HYPH -) (, ,) (NN F5) (HYPH -) (, ,) (CC and) (NN βT) (HYPH -)) (VBN targeted)) (NNS mutations)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG engineering) (NP (NML (NML (NML (NN Y)) (PP (SYM –) (NP (NN F)))) (, ,) (NML (NML (NN Y)) (PP (SYM –) (NP (NN I)))) (, ,) (CC or) (NML (NN frameshift))) (NNS mutations)) (PP-LOC (IN in) (NP (DT the) (JJ same) (VBG targeting) (NN vector)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2A)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN F7) (NN mutation)) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG targeting) (NP (DT the) (NN F5) (JJ heterozygous) (NML (NML (JJ embryonic) (NN stem)) (-LRB- -LRB-) (NML (NN ES))) (-RRB- -RRB-) (NNS cells))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2B)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-3 (NP (NNS Cells)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD contained) (NP (DT all) (NNS mutations)) (PP-LOC (IN on) (NP (DT the) (JJ same) (NN allele))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN determined) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NNP Southern) (NN blotting)))))))))) (, ,) (VP (VBD were) (VP (VBN used) (NP-3 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (DT the) (NN F7) (NN line))))))) (. .)) )
( (S (NP-SBJ (DT All) (NN mutant) (NNS mice)) (VP (VBD were) (ADJP-PRD (JJ viable) (CC and) (JJ fertile)) (PP (IN as) (NP (NNS homozygotes))) (PP (IN except) (NP (NP (NP (DT the) (NN truncation) (NN allele)) (, ,) (NP (NN βT))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ lacks) (NP (NP (NP (DT the) (JJ second) (NN half)) (PP (IN of) (NP (DT the) (NN kinase) (NN domain)))) (CC and) (NP (DT the) (ADJP (NP (NP (NN SHP) (HYPH -) (CD 2)) (HYPH -) (CC and) (NP (NN PLCγ)) (HYPH -)) (VBG binding)) (NNS sites))))))))) (. .)) )
( (S (PP (VBN Based) (PP (IN on) (NP (NP (DT a) (JJ similar) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (NN PDGFRβ)))))) (, ,) (S (S (NP-SBJ (PRP we)) (VP (VBP assume) (SBAR (IN that) (S (NP-SBJ (DT this) (NN receptor)) (VP (VBZ is) (ADJP-PRD (ADJP (NN kinase) (JJ deficient)) (CC and) (ADJP (JJ incapable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG inducing) (NP (NN DNA) (NN synthesis)))))))))))) (, ,) (CC but) (S (NP-SBJ (PRP it)) (ADVP-TMP (RB still)) (VP (MD should) (VP (VP (VB bind) (NP (NN ligand))) (CC and) (VP (VBP undergo) (NP (NN receptor) (NN downregulation))) (CIT (-LRB- -LRB-) (NNP Escobedo) (FW et) (FW al.) (CD 1988) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (NNS Embryos)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NN βT) (NN allele))))) (VP (VBP die) (ADVP-TMP (RB perinatally)) (PP (IN with) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ identical) (PP (IN to) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (ADJP (NN PDGFRβ) (JJ null)) (NNS embryos))))))))) (. .)) )
( (S (NP-SBJ (NN E18) (NNS embryos)) (VP (VBP exhibit) (NP (NN edema) (CC and) (NN hemorrhaging)) (PP-LOC (IN in) (NP (NP (JJ multiple) (NNS tissues)) (, ,) (PP (VBG including) (NP (DT the) (NML (NN kidney) (, ,) (NN brain) (, ,) (CC and) (NN skin)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP-SBJ-1 (NN PDGFRβ) (NN kinase) (NN activity)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (NN v) (HYPH /) (NN p)) (NN development))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (DT the) (NN receptor)) (VP (MD can) (RB not) (VP (VB function) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN kinase) (NN activity))))) (, ,) (PP (IN unlike) (NP (NP (DT another) (NN RTK)) (, ,) (NP (NML (JJ vascular) (JJ endothelial) (NML (NN cell) (NN growth)) (NN factor)) (NN receptor) (CD 1)) (CIT (-LRB- -LRB-) (NNP Hiratsuka) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-)))))))))) (. .)) )
( (HEADING (NP (NP (NN Identification)) (PP (IN of) (NP (NML (NN V) (HYPH /) (NN P)) (NNS Cells))))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBD examined) (NP (NP (DT the) (NN blood) (NNS vessels)) (PP (IN of) (NP (NML (NN F) (NN series)) (JJ homozygous) (NNS mice)))) (PP-MNR (IN by) (NP (NN histology)))) (CC and) (VP (VBD detected) (NP (DT no) (JJ gross) (NNS abnormalities))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB obtain) (NP (NP (DT a) (ADJP (RBR more) (JJ global)) (NN perspective)) (PP (IN of) (NP (NML (NML (NN v) (HYPH /) (NN p)) (NN cell)) (NNS populations))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD introduced) (NP (DT the) (NN XlacZ4) (JJ transgenic) (NN marker)) (PP (IN into) (NP (PRP$ our) (NML (NN F) (NN series)) (NN mutant) (NNS mice)))) (. .)) )
( (S (NP-SBJ (DT The) (NN XlacZ4) (JJ transgenic) (NN mouse)) (VP (VBZ expresses) (NP (JJ nuclear) (NN β) (HYPH -) (NN galactosidase)) (PP-LOC (IN in) (NP (NP (JJ certain) (NNS populations)) (PP (IN of) (NP (JJ differentiated) (, ,) (JJ nonproliferating) (NML (NN v) (HYPH /) (NN p)) (NNS cells))))) (PP-LOC (IN in) (NP (NP (DT the) (NN embryo)) (CC and) (NP (DT the) (JJ adult)))) (CIT (-LRB- -LRB-) (NNP Tidhar) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP-LOC (RB below))))) (, ,) (S-MNR (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBG using) (NP (DT this) (NN marker)) (PP-LOC (IN in) (NP (JJ adult) (NNS animals))))) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBD identified) (NP (JJ vascular) (NNS defects)) (PP-LOC (IN in) (NP (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS mice))) (PP-LOC (IN in) (NP (NP (DT the) (NNS tissues)) (PP (IN of) (NP (DT the) (NML (NNS eyes) (, ,) (NNS hearts) (, ,) (CC and) (NNS brains)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Figures) (NML (CD 7) (, ,) (CD 8) (, ,) (CC and) (CD 9))))) (: ;) (S (NP-SBJ-3 (NNS data)) (RB not) (VP (VBN shown) (NP-3 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This) (NN observation)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (CC both) (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS alleles)) (VP (VBP function) (ADVP (RB suboptimally)) (PP-LOC (IN in) (NP (NP (NNS tissues)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB require) (NP (NN PDGFRβ) (NN signal) (NN transduction))))))))))) (CIT (-LRB- -LRB-) (NNP Lindahl) (FW et) (FW al.) (CD 1997a) (: ;) (NNP Hellström) (FW et) (FW al.) (CD 1999) (: ;) (NNP Enge) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (NP (DT both)) (PP (IN of) (NP (DT these) (NNS mutations)))) (VP (VBP cause) (NP (JJ notable) (NNS phenotypes)) (PP-LOC (IN in) (NP (DT some) (NML (NN v) (HYPH /) (NN p)) (NNS populations)))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (RB not) (VP (VBN observed) (NP (NNS pathologies)) (PP-LOC (IN in) (NP (NP (DT all) (NNS populations)) (PP (IN of) (NP (ADJP (NN PDGFRβ) (HYPH -) (JJ dependent)) (NML (NN v) (HYPH /) (NN p)) (NNS cells))))))) (. .)) )
( (S (NP-SBJ (NP (NML (NN V) (HYPH /) (NN p)) (NN cell) (NNS populations)) (PP (IN with) (NP (DT no) (JJ overt) (NN phenotype))) (PP-LOC (IN in) (NP (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS mice)))) (VP (VBP include) (NP (NP (DT the) (NML (NN kidney) (NML (NML (JJ mesangial) (NNS cells)) (CC and) (NML (NNS pericytes))))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN skin)) (CC and) (NML (JJ skeletal) (NN muscle)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VP (VBN observed) (NP (DT a) (JJ modest) (NN decrease)) (PP (IN in) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS nuclei)))) (ADJP (VBP present) (PP-LOC (IN in) (NP (NML (NML (NN F5) (HYPH /) (NN F5)) (CC and) (NML (NN F5) (HYPH /) (SYM −))) (NN kidney) (NNS glomeruli))))))) (, ,) (CC but) (VP (VBP have) (RB not) (VP (VBN detected) (NP (NP (NN glomerulosclerosis)) (PP (IN with) (NP (NNP Masson) (NN trichrome) (NN stain)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN lack)) (PP (IN of) (NP (DT any) (JJ pathological) (NN phenotype))) (PP-LOC (IN in) (NP (DT these) (NNS tissues)))) (VP (VBZ suggests) (SBAR (CC either) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN reduction)) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)))) (VP (VBZ is) (ADJP-PRD (ADJP (RBR less) (JJ severe)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (ADJP (NN PDGFRβ) (JJ null)) (NNS mice)))))))))) (, ,) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NN PDGFRα)) (VP (MD may) (VP (VB be) (VP (VBN coexpressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT these) (JJ same) (NNS tissues)))))))) (, ,) (CC or) (SBAR (IN that) (S (NP-SBJ (DT these) (NNS tissues)) (VP (MD can) (VP (VB function) (ADVP (RB adequately)) (PP (ADVP (RB even)) (IN with) (NP (VBN reduced) (NML (NML (NN v) (HYPH /) (NN p)) (NN cell)) (NNS numbers))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-1 (NP (DT some) (NNS populations)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)))) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (ADJP (RBR more) (JJ dependent) (PP (IN on) (NP (NN PDGFRβ) (NN signal) (NN transduction)))) (PP (IN than) (NP (NNS others)))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD reasoned) (SBAR (IN that) (S (NP-SBJ-2 (DT the) (NN PDGFRα)) (VP (MD might) (VP (VB be) (VP (VBN coexpressed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (ADJP (RB less) (HYPH -) (VBN affected)) (NML (NN v) (HYPH /) (NN p)) (NNS populations))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NN PDGFRα)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NML (JJ mesenchymal) (NN cell)) (NNS lineages))))) (CIT (-LRB- -LRB-) (NNP Schatteman) (FW et) (FW al.) (CD 1992) (: ;) (NNP Lindahl) (FW et) (FW al.) (CD 1997b) (: ;) (NNP Takakura) (FW et) (FW al.) (CD 1997) (: ;) (NNP Zhang) (FW et) (FW al.) (CD 1998) (: ;) (NNP Karlsson) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))))) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBD wanted) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP-SBJ (DT any) (NML (NN v) (HYPH /) (NN p)) (NNS populations)) (VP (VBP express) (NP (DT the) (NN PDGFRα))))) (CC or) (SBAR (IN whether) (S (NP-SBJ-3 (PRP it)) (VP (MD may) (VP (VB be) (VP (VBN upregulated) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NML (NN F) (NN series)) (NNS mice))))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBD crossed) (NP (NP (NP (DT the) (NN PDGFRαGFP) (NN line)) (PP (IN of) (NP (NN mouse)))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ expresses) (NP (DT a) (ADJP (JJ nuclear) (HYPH -) (VBN localized)) (NML (NML (JJ green) (JJ fluorescent) (NN protein)) (-LRB- -LRB-) (NML (NN GFP)))) (-RRB- -RRB-) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NN PDGFRα) (NN promoter))))) (CIT (-LRB- -LRB-) (NNP Hamilton) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))))) (, ,) (PP (IN with) (NP (DT the) (NN F5) (NN mutant) (NNS mice)))) (CC and) (VP (VBD compared) (NP (DT the) (NN GFP) (NN expression) (NN pattern)) (PP (IN to) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))) (PP-LOC (IN in) (NP (DT the) (NML (NN kidney) (, ,) (NN eye) (, ,) (CC and) (NN brain)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (: ;) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (CD three) (JJ independent) (NNS markers)) (NP-2 (-NONE- *ICH*))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB designate) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))))) (: :) (NP-2 (NP (NP (NML (JJ smooth) (NN muscle)) (NN actin) (NN α)) (-LRB- -LRB-) (NP (NN αSMA))) (-RRB- -RRB-) (, ,) (NP (NN desmin)) (, ,) (CC and) (NP (DT the) (NN XlacZ4) (NN transgene))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (ADJP (NN PDGFRα) (HYPH -) (VBG expressing)) (NNS cells)) (VP (VBP are) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ same) (NNS tissues)) (PP (IN as) (NP (NML (NN v) (HYPH /) (NN p)) (NN cell) (NNS markers))))))))) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT no) (VBG overlapping) (NN expression)) (PP (IN of) (NP (NN GFP))) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN cell) (NNS markers)))))) (PP-LOC (IN in) (NP (DT the) (NML (NNS arteries) (CC or) (NNS veins)))) (PP-LOC (IN in) (NP (NP (DT the) (NNS vessels)) (PP (IN of) (NP (DT the) (NML (NN eye) (CC and) (NN brain))))))) (. .)) )
( (S (S (NP-SBJ (ADJP (NN PDGFRα) (HYPH -) (VBG expressing)) (NNS cells)) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (JJ absent) (PP (IN from) (NP (NP (DT the) (JJR larger) (NNS vessels)) (PP (IN of) (NP (DT the) (NN kidney)))))))) (, ,) (CC but) (S (NP-SBJ-1 (NP (DT a) (NN population)) (PP (IN of) (NP (NN GFP+) (NNS cells)))) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN within) (NP (DT the) (NN kidney) (NN glomerulus))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3A)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (DT These)) (VP (MD may) (VP (VB be) (NP-PRD (CC either) (NP (NN kidney) (JJ mesangial) (NNS cells)) (CC or) (NP (JJ vascular) (JJ adventitial) (NNS fibroblasts))))) (. .)) )
( (S (NP-SBJ (DT Both)) (VP (VBP are) (NP-PRD (NP (NNS populations)) (PP (IN of) (NP (NP (NNS cells)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB express) (NP (DT the) (NN PDGFRα)))))))))))) (CIT (-LRB- -LRB-) (NNP Seifert) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-1 (NN PDGFRα)) (VP (VP (VBZ is) (RB not) (VP (VBN expressed) (CC or) (VBN upregulated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (CD two)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ affected)) (NNS tissues)) (PP (IN of) (NP (DT the) (NN mutant) (NNS mice)))))) (, ,) (NP (NP (DT the) (NN eye)) (CC and) (NP (DT the) (NN brain))))))) (, ,) (CC but) (VP (MD could) (VP (VB be) (VP (VBG functioning) (PP-MNR (IN as) (NP (DT a) (JJ surrogate) (NN coreceptor))) (PP (IN with) (NP (DT the) (NN PDGFRβ)))))))))) (. .)) )
( (HEADING (NP (NML (NN V) (HYPH /) (NN P)) (NN Development))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ-2 (NP (DT the) (NN reduction)) (PP (IN in) (NP (NN v) (HYPH /) (NN p)))) (VP (VBD was) (VP (VBN caused) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (JJ gradual) (NN loss)) (CC or) (NP (DT a) (JJ developmental) (NN defect))))))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD examined) (NP (NN pericyte) (NNS populations)) (PP-LOC (IN in) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN mutant))) (NNS embryos)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN XlacZ4) (NN mouse) (NN marker)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (JJ specific) (NML (NN v) (HYPH /) (NN p)) (NN cell) (NNS populations)) (ADVP-TMP (ADVP (RB as) (RB early)) (PP (IN as) (NP (NN E12.5)))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD chose) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB observe) (NP (NNS pericytes)) (PP-TMP (IN at) (NP (NN E14.5))) (SBAR-PRP (IN because) (S (PP-TMP (IN at) (NP (DT this) (NN timepoint))) (NP-SBJ (NN v) (HYPH /) (NN p)) (VP (VBP are) (ADJP-PRD (JJ abundant)) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS animals))) (PP-LOC (IN in) (NP (NP (JJ several) (NNS tissues)) (, ,) (PP (VBG including) (NP (DT the) (NML (NML (VBG developing) (JJ spinal) (NN cord)) (CC and) (NML (JJ intercostal) (NN vasculature)))))))))))))) (. .)) )
( (S (NP-SBJ (NN Figure) (CD 4)) (VP (VBZ demonstrates) (NP (NP (NML (JJ whole) (HYPH -) (NN mount)) (NN visualization)) (PP (IN of) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN cell) (NNS populations)))) (PP-LOC (IN in) (NP (NP (NN E14.5) (NML (JJ wild) (HYPH -) (NN type)) (NNS embryos)) (CC and) (NP (NP (DT the) (ADJP (RBS most) (JJ severe)) (NML (NN F) (NN series)) (NN mutant) (NN embryo)) (-LRB- -LRB-) (NP (NN F7) (HYPH /) (SYM −)))) (-RRB- -RRB-))) (. .)) )
( (S (PP-TMP (IN After) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG examining) (NP (NP (JJ several) (NNS litters)) (PP (IN of) (NP (NP (NML (NN F) (NN series)) (NN mutant) (NNS embryos)) (VP (VBG bearing) (NP (DT the) (NN XlacZ4) (NN marker))))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBD was) (ADJP-PRD (JJ clear)) (SBAR-1 (IN that) (S (NP-SBJ-2 (NP (DT the) (JJ entire) (NN panel)) (PP (IN of) (NP (NML (NN F) (NN series)) (JJ homozygous) (NN mutant) (NNS embryos)))) (VP (MD could) (VP (VB be) (VP (VBN distinguished) (NP-2 (-NONE- *)) (PP (IN from) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS embryos))) (PP-MNR (ADVP (RB simply)) (IN by) (NP (NP (DT the) (NN degree)) (SBAR (WHADVP-4 (IN that)) (S (NP-SBJ (NN blood) (NNS vessels)) (VP (VBD had) (VP (VBN acquired) (NP (NN v) (HYPH /) (NN p)) (ADVP-4 (-NONE- *T*)))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-3 (NNS data)) (RB not) (VP (VBN shown) (NP-3 (-NONE- *)))) (-RRB- -RRB-)))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB obtain) (NP (NP (DT a) (JJ quantitative) (NN view)) (PP (IN of) (NP (DT these) (NNS results))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD chose) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB focus) (PP (IN on) (NP (DT the) (NML (JJ spinal) (NN cord)) (NN pericyte) (NN population))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS cells)) (VP (VP (VBP begin) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB form) (PP-TMP (IN at) (NP (NN E10.5))) (PP-MNR (IN in) (NP (DT a) (ADJP (JJ rostral) (HYPH -) (PP (IN to) (HYPH -) (ADJP (JJ caudal)))) (NN fashion))) (PP-LOC (IN in) (NP (DT the) (NN embryo))))))) (CC and) (VP (VB require) (NP (NN PDGFRβ) (NNS signals)) (PP-PRP (IN for) (NP (NN development)))) (CIT (-LRB- -LRB-) (NNP Levéen) (FW et) (FW al.) (CD 1994) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NNS Cross-sections)) (PP (IN through) (NP (DT the) (NML (NML (VBG developing) (JJ spinal) (NN cord)) (-LRB- -LRB-) (NML (JJ neural) (NN tube)))))) (-RRB- -RRB-) (VP (VBP provide) (NP (NP (DT a) (ADJP (RB relatively) (JJ uniform)) (NN area)) (PP (IN for) (NP (NN quantitation))))) (. .)) )
( (S (S (NP-SBJ (PRP We)) (VP (MD can) (ADVP (RB consistently)) (VP (VB identify) (NP (NP (DT a) (JJ particular) (NN maturation) (NN stage)) (PP (IN of) (NP (DT the) (VBG developing) (NN vasculature)))) (PP (VBN based) (PP (IN on) (NP (NP (PRP$ its) (JJ axial) (NN level)) (PP-LOC (IN within) (NP (DT the) (NN embryo))))))))) (, ,) (CC and) (S (NP-SBJ-1 (DT the) (NNS pericytes)) (VP (MD can) (ADVP-TMP (RB often)) (VP (VB be) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN as) (NP (VBN isolated) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-)))))) (. .)) )
( (S (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG Using) (NP (NP (DT the) (JJ entire) (NN panel)) (PP (IN of) (NP (NN PDGFRβ) (NN mutant) (NNS mice)))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD compared) (NP (NN pericyte) (NNS numbers)) (PP (IN between) (NP (DT the) (JJ different) (NML (NN F) (NN series)) (NNS mutants))) (PRN (-LRB- -LRB-) (NP (NNS Figures) (NML (CD 5) (CC and) (CD 6))) (-RRB- -RRB-))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (NP (DT all) (NNS mutants)) (VP (VBN examined) (NP (-NONE- *)))) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (DT the) (NN F1) (NN mutation))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NP (NP (DT a) (VBN decreased) (NN incidence)) (PP (IN of) (NP (NNS pericytes)))) (SBAR (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS embryos))) (ADVP-TMP-2 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN reduction)) (PP (IN in) (NP (NN pericyte) (NNS numbers)))) (VP (VBD ranged) (PP (PP (IN from) (NP (CD 42) (NN %))) (PP (IN to) (NP (CD 77) (NN %))))) (. .)) )
( (S (NP-SBJ (DT This) (NN reduction)) (VP (VBD was) (ADJP-PRD (JJ present)) (PP-LOC (PP (IN at) (NP (NP (DT the) (ADJP (RBR more) (JJ mature)) (JJ axial) (NN level)) (PP (IN of) (NP (DT the) (NN heart))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN at) (NP (NP (DT the) (JJ axial) (NN level)) (PP (IN of) (NP (DT the) (NN kidney))))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN F7) (HYPH /) (NN F7)) (NN mutant) (NNS embryos)) (VP (VBP are) (NP-PRD (NP (DT the) (JJ only) (NNS embryos)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD exhibited) (NP (NP (DT a) (NN difference)) (PP (IN between) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS pericytes))) (PP-LOC (IN at) (NP (DT the) (NN heart) (NN level)))) (CC versus) (NP (NP (DT the) (NN number)) (PP-LOC (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (NN kidney)))))))))))))) (. .)) )
( (S (NP-SBJ (DT All) (JJ other) (NNS mutants)) (VP (VBD demonstrated) (NP (JJ similar) (NNS numbers)) (PP-LOC (IN at) (NP (DT both) (NNS levels))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-1 (NN pericyte) (NN development)) (VP (VP (VBZ is) (VP (VBN disrupted) (NP-1 (-NONE- *)))) (CC and) (VP (VBZ does) (RB not) (VP (VB reach) (NP (NN homeostasis)) (SBAR-TMP (IN as) (S (NP-SBJ (DT the) (NN tissue)) (VP (VBZ matures)))))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (DT the) (NN F7)) (VP (VBZ is) (NP-PRD (DT the) (ADJP (ADVP (RBS most) (RB severely)) (JJ affected)) (NN allele))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NN difference)) (PP (IN between) (NP (DT the) (NML (NN heart) (CC and) (NN kidney)) (NNS levels)))) (VP (VBZ is) (PP-PRD (IN due) (IN to) (NP (NP (DT a) (JJ developmental) (NN delay)) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NN formation))))))))) (. .)) )
( (S (NP-SBJ (NN Pericyte) (NN development)) (VP (MD may) (ADVP-TMP (RB still)) (VP (VB be) (VP (VBG proceeding) (PP-LOC (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (NN kidney))))) (PP-LOC (IN in) (NP (DT these) (NNS embryos)))))) (. .)) )
( (S (PP-LOC (IN At) (NP (NP (DT the) (ADJP (RBR more) (JJ mature)) (NN level)) (PP (IN of) (NP (DT the) (NN heart))))) (, ,) (NP-SBJ (DT the) (NML (NML (NN F7) (HYPH /) (NN F7)) (NN pericyte)) (NNS populations)) (VP (VP (VBP have) (VP (VBN reached) (NP (DT a) (NML (JJ steady) (HYPH -) (NN state)) (NN level)))) (CC and) (VP (VBP resemble) (NP (NP (NML (NN v) (HYPH /) (NN p)) (NNS numbers)) (ADJP (ADJP (RBR more) (JJ similar)) (PP (IN to) (NP (NP (DT those)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN F5) (HYPH /) (NN F5)) (NNS embryos)))))))))) (. .)) )
( (S (ADVP-TMP (RB Previously)) (, ,) (NP-SBJ (JJ chimeric) (NN analysis)) (VP (VBD had) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NN PDGFRβ) (JJ heterozygous) (NNS cells)) (VP (VBP do) (RB not) (VP (VB contribute) (ADVP (RB extensively)) (PP (IN to) (NP (DT the) (NML (NML (JJ smooth) (NN muscle)) (NN cell)) (NN compartment))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (JJ heterozygous) (NNS cells)) (VP (MD may) (VP (VB have) (NP (JJ reduced) (NML (NN v) (HYPH /) (NN p)) (JJ developmental) (NN potential)))))))))))) (CIT (-LRB- -LRB-) (NNP Crosby) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-)))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB find) (PRT (RP out)) (SBAR (IN whether) (S (NP-SBJ (NN receptor) (NNS levels)) (VP (VBD had) (NP (DT any) (NN impact)) (PP (IN on) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))) (PP-LOC (IN in) (NP (PRP$ our) (NN system))))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD crossed) (NP (NP (NNS animals)) (VP (VBG bearing) (NP (DT the) (ADJP (NN PDGFRβ) (JJ null)) (NN allele)))) (PP (IN to) (NP (PRP$ our) (NN mutant) (NN series))) (PRN (-LRB- -LRB-) (NP (NNS Figures) (NML (CD 5B) (CC and) (CD 6B))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD observed) (NP (NP (DT an) (ADJP (RB even) (JJ further)) (NN reduction)) (PP (IN in) (NP (NN pericyte) (NNS levels)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NML (NML (CD 70) (NN %)) (PP (SYM –) (NP (CD 92) (NN %)))) (NN decrease)) (PP (IN in) (NP (NNS pericytes))))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS embryos))) (ADVP-TMP-2 (-NONE- *T*)))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (NP (RB even) (DT the) (NML (NN PDGFRβ+) (HYPH /) (SYM −)) (NNS embryos)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP exhibit) (NP (DT a) (NML (QP (RB approximately) (CD 50)) (NN %)) (NN reduction)) (PP-LOC (IN in) (NP (NN PDGFRβ) (NN messenger) (NN RNA)))))) (CIT (-LRB- -LRB-) (NNP Soriano) (CD 1994) (-RRB- -RRB-))) (, ,) (VP (VBP demonstrate) (NP (NP (DT a) (NML (QP (RB nearly) (CD 40)) (NN %)) (NN decrease)) (PP (IN in) (NP (NNS pericytes))))) (. .)) )
( (S (NP-SBJ (DT This) (NN result)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN quantity)) (PP (IN of) (NP (NN receptor)))) (VP (VBZ impacts) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS pericytes)))))))) (. .)) )
( (S (NP-SBJ (NP (DT Another) (NN observation)) (PP (IN from) (NP (DT this) (NNS data)))) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ (RB even) (DT the) (NML (NN F7) (HYPH /) (SYM −)) (NNS embryos)) (VP (MD can) (VP (VB induce) (NP (NN cell) (NN development)) (PP (IN at) (NP (NP (NNS levels)) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (DT the) (NN null))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN fact))) (, ,) (NP-SBJ (DT the) (NML (NN F7) (HYPH /) (SYM −)) (NNS animals)) (VP (VBP survive) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (DT the) (NN PDGFRβ) (NNS nulls)) (VP (VBP do) (RB not) (VP (-NONE- *?*)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (NP-PRD (DT a) (ADJP (RB rather) (JJ surprising)) (NN result)) (PP (VBN given) (SBAR (IN that) (S (NP-SBJ-2 (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (JJ downstream) (NML (NN signal) (NN transduction)) (NNS molecules)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB directly)) (VP (VBP interact) (PP (IN with) (NP (DT the) (NN receptor))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN dissociated) (NP-2 (-NONE- *))))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (NP (JJS most)) (PP (IN of) (NP (DT the) (NML (NN F) (NN series)) (NNS alleles)))) (VP (VBP demonstrate) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))))))) (, ,) (NP-SBJ (DT the) (NN F1) (NN allele)) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (JJ apparent) (NN increase)) (PP (IN in) (NP (NML (JJ spinal) (NN cord)) (NNS pericytes)))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (DT the) (NN increase)) (VP (VBZ is) (ADJP-PRD (RBS most) (JJ pronounced)) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (PRP we)) (VP (VBP compare) (NP (DT the) (NN F1) (NN hemizygote)) (PP (IN to) (NP (DT the) (NN PDGFRβ) (NN heterozygote))) (ADVP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))))) (, ,) (NP-SBJ-2 (DT an) (NN increase)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN observed) (NP-2 (-NONE- *)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NP (NML (NN F1) (HYPH /) (NN F1)) (NNS embryos)) (CC and) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS embryos))) (ADVP-TMP-3 (-NONE- *T*))))))) (. .)) )
( (S (PP (IN In) (NP (NN fact))) (, ,) (NP-SBJ (NP (DT the) (NN level)) (PP (IN of) (NP (NNS pericytes))) (PP-LOC (IN in) (NP (DT the) (NML (NN F1) (HYPH /) (SYM −)) (NNS embryos)))) (VP (VBZ is) (ADJP-PRD (RB very) (JJ similar) (PP (IN to) (NP (NP (DT those)) (PP-LOC (IN in) (NP (DT the) (JJ wild) (HYPH -) (NN type))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP demonstrate) (NP (CD two) (JJ interesting) (NNS findings))) (. .)) )
( (S (NP-SBJ (CD One)) (VP (VBZ is) (SBAR-PRD (SBAR (IN that) (S (NP-SBJ (NN RasGAP)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NML (NN PDGFRβ) (NN signal)) (NN attenuation))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT this) (NN pathway)))) (VP (VBZ results) (PP (IN in) (NP (JJ increased) (NN PDGFRβ) (NNS signals)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN second)) (VP (VBZ is) (SBAR-PRD (SBAR (IN that) (S (NP-SBJ-1 (NML (NN v) (HYPH /) (NN p)) (NNS numbers)) (VP (MD may) (RB not) (VP (VB be) (ADVP (RB tightly)) (VP (VBN controlled) (NP-1 (-NONE- *))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NN PDGFRβ) (NN signaling)) (VP (MD can) (VP (VB result) (PP (IN in) (NP (JJR more) (NNS cells))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (DT the) (NN signaling) (NNS pathways)) (VP (VBD affected) (NP (JJ other) (NML (NN v) (HYPH /) (NN p)) (NNS populations)) (PP-MNR (IN in) (NP (DT the) (JJ same) (NN manner))))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN population)) (PP-LOC (IN in) (NP (DT the) (NN retina))))) (. .)) )
( (S (NP-SBJ-2 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously)) (SBAR-1 (IN that) (S (NP-SBJ (NML (NN PDGFB) (CC and) (NN PDGFRβ)) (NN signaling)) (VP (VBZ controls) (NP (NN pericyte) (NN development)) (PP-LOC (IN in) (NP (DT the) (NN eye)))))) (CIT (-LRB- -LRB-) (NNP Benjamin) (FW et) (FW al.) (CD 1998) (: ;) (NNP Klinghoffer) (FW et) (FW al.) (CD 2001) (: ;) (NNP Enge) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (JJ Adult) (NNS mice)) (ADJP (JJ transheterozygous) (PP (IN for) (NP (NP (CD one) (JJ null) (NN allele)) (CC and) (NP (CD one) (NML (NN F5) (CC or) (NN F7)) (NN allele)))))) (VP (VBD exhibited) (NP (JJ severe) (NN eye) (NNS defects))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS defects)) (VP (VBD were) (ADVP-TMP (RB first)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (PP (IN as) (NP (DT an) (NN opacity))) (CC and) (PP (ADVP-TMP (RB sometimes)) (IN as) (NP (JJ visible) (NN hemorrhage)))) (PP-LOC (IN in) (NP (DT the) (NN eye))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 7A)) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *)) (PP (IN for) (NP (NML (NN PDGFRβ) (CC and) (NN PDGFB)) (NN signaling) (NNS mutants)))))) (CIT (-LRB- -LRB-) (NNP Klinghoffer) (FW et) (FW al.) (CD 2001) (: ;) (NNP Enge) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN F5) (CC and) (NN F7)) (JJ hemizygous) (NN mutant) (NNS mice)) (VP (VBD possessed) (NP (NP (JJR fewer) (JJ discontinuous) (NN blood) (NNS vessels)) (CC and) (NP (NP (NN overgrowth)) (PP (IN of) (NP (JJ retinal) (NNS cells)))))) (. .)) )
( (S (NP-SBJ (DT This) (NN phenotype)) (VP (VP (VBD occurred) (PP (PP (IN with) (NP (NML (CD 100) (NN %)) (NN penetrance))) (, ,) (CC but) (PP (IN with) (NP (JJ variable) (NN severity)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 7C)) (-RRB- -RRB-))) (, ,) (CC and) (VP (VBD was) (ADJP-PRD (JJ detectable)) (ADVP-TMP (RB sometimes)) (ADVP-TMP (ADVP (RB as) (RB early)) (PP (IN as) (PP (NP-ADV (CD 4) (NN d)) (IN after) (NP (NN birth))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN presence)) (PP (IN of) (NP (DT a) (JJ pathological) (NN condition)))) (VP (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS alleles)) (VP (VBP have) (NP (JJ compromised) (NN receptor) (NN function)) (SBAR-ADV (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN F1) (, ,) (NN F2) (, ,) (CC and) (NN F3)) (NNS alleles))) (ADVP-TMP-2 (-NONE- *T*))))))))) (CC and) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP-SBJ (JJ retinal) (NNS pericytes)) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN PDGFRβ) (NN signaling) (NNS pathways)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN disrupted) (NP-3 (-NONE- *T*)))))))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB examine) (NP (DT the) (JJ retinal) (NNS pericytes)) (PP-LOC (IN in) (NP (DT the) (JJ entire) (NN F) (NN series)))))) (, ,) (NP-SBJ-1 (PRP we)) (ADVP-TMP (RB again)) (VP (VBD used) (NP (NP (NNS mice)) (VP (VBG bearing) (NP (DT the) (NN XlacZ4) (NN transgene))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NP (CD 4) (NN wk)) (PP (IN of) (NP (NN age))))) (NP-SBJ-1 (DT the) (JJ retinal) (NN vasculature)) (VP (VP (VBZ is) (ADJP-PRD (JJ mature))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NML (NN lens)) (CC and) (NML (JJ pigmented) (NN epithelium))))) (PP-PRP (IN for) (NP (NN visualization))))))) (. .)) )
( (S (S (NP-SBJ (NN Figure) (CD 8)) (VP (VBZ illustrates) (SBAR (IN that) (S (NP-SBJ (NP (NNS homozygotes)) (PP (IN for) (NP (DT the) (NML (NN F1) (, ,) (NN F2) (, ,) (CC and) (NN F3)) (NN mutant) (NNS alleles)))) (VP (VBP are) (ADJP-PRD (JJ indistinguishable) (PP (IN from) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS eyes))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (NML (NML (NN F5) (HYPH /) (NN F5)) (CC and) (NML (NN F7) (HYPH /) (NN F7))) (NNS eyes)) (VP (VBP exhibit) (NP (NP (JJ reduced) (NNS numbers)) (PP (IN of) (NP (NNS pericytes)))))) (. .)) )
( (S (PP (ADVP (RB Even)) (IN without) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB quantitate) (NP (DT these) (NNS differences))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ clear)) (SBAR-1 (IN that) (S (NP-SBJ (DT the) (NML (NML (NN PDGFRβ+) (HYPH /) (SYM −)) (, ,) (NML (NN F5) (HYPH /) (NN F5)) (, ,) (NML (NN F7) (HYPH /) (NN F7)) (, ,) (NML (NN F5) (HYPH /) (SYM −)) (, ,) (CC and) (NML (NN F7) (HYPH /) (SYM −))) (NN mutant) (NNS retinas)) (VP (VBP have) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN v) (HYPH /) (NN p)))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS eyes))) (ADVP-TMP-3 (-NONE- *T*))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG reinforcing) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (JJ multiple) (NN PDGFRβ) (NN signal) (NN transduction) (NNS pathways)))) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NN development))))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ final) (NN tissue)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NML (NN v) (HYPH /) (NN p)) (NN formation)) (ADVP-LOC-1 (-NONE- *T*))))))) (VP (VBZ is) (NP-PRD (DT the) (NN heart))) (. .)) )
( (S (NP-SBJ (NML (NN F2) (CC and) (NN F3)) (NML (NNS homozygotes) (CC and) (NNS transheterozygotes))) (VP (VBD were) (ADJP-PRD (JJ indistinguishable) (PP (IN from) (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (ADJP (JJ heterozygous))) (NNS hearts)))) (, ,) (ADVP (RB respectively))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (NP (PRP$ our) (NNS observations)) (PP-LOC (IN in) (NP (NP (DT the) (NN eye)) (CC and) (NP (DT the) (JJ nervous) (NN system)))))))) (, ,) (NP-SBJ (DT the) (NML (NN F5) (CC and) (NN F7)) (NN mutant) (NNS alleles)) (VP (VBP display) (NP (NNS abnormalities)) (PP-LOC (IN in) (NP (NP (DT the) (JJ vascular) (NN coating)) (PP (IN of) (NP (PRP$ their) (JJ coronary) (NML (NNS arteries) (CC and) (NNS veins)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 9)) (: ;) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NML (NML (NN F5) (HYPH /) (SYM −)) (CC and) (NML (NN F7) (HYPH /) (SYM −))) (NNS mice)) (ADVP-TMP (RB often)) (VP (VBD exhibited) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NN heart) (NNS abnormalities)) (, ,) (PP (VBG including) (NP (NP (JJ enlarged) (NNS ventricles)) (, ,) (NP (JJ increased) (NML (NML (NN heart)) (PP (SYM :) (NP (NN body) (NN mass)))) (NN ratio)) (, ,) (NP (JJ dilated) (NN atria)) (, ,) (CC and) (NP (NN fibrosis))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (DT the) (NML (NN F1) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB have) (NP (ADJP (RBR more) (JJ extensive)) (NML (NN v) (HYPH /) (NN p)) (NN coating)) (PP-LOC (IN on) (NP (PRP$ their) (JJ coronary) (NNS arteries)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 9)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (DT the) (NNS data)) (PP (IN from) (NP (NP (DT the) (JJ nervous) (NN system)) (CC and) (NP (DT the) (NN eye)))))))) (, ,) (NP-SBJ (DT the) (NML (NN F5) (CC and) (NN F7)) (NN mutant) (NNS alleles)) (VP (VBP have) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))))) (. .)) )
( (S (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN Taken) (NP-1 (-NONE- *)) (ADVP (RB together)))) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP demonstrate) (NP (NP (JJ several) (JJ important) (NNS findings)) (PP (IN for) (NP (NN PDGFRβ) (NN signal) (NN transduction))))) (. .)) )
( (S (ADVP (RB First)) (, ,) (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS pericytes)) (VP (VBN formed) (NP (-NONE- *)))))) (ADVP (RB directly)) (VP (VBZ correlates) (PP (IN with) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN signaling) (NNS pathways)) (VP (VBG transducing) (NP (NN PDGFRβ) (NN activity)))))))) (. .)) )
( (S (ADVP (RB Second)) (, ,) (NP-SBJ-1 (NP (DT a) (NN reduction)) (PP (IN in) (NP (NNS pericytes)))) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (SBAR-TMP (ADVP (RB even)) (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (NP (RB only) (DT the) (NN amount)) (PP (IN of) (NP (NN receptor)))) (VP (VBZ is) (VP (VBN affected) (NP-2 (-NONE- *)) (ADVP-TMP-3 (-NONE- *T*)))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (ADJP (NP (NN SH2) (NN domain)) (HYPH -) (VBG containing)) (NN proteins)) (VP (VBP impact) (NP (NML (NN v) (HYPH /) (NN p)) (NNS numbers))))) (, ,) (NP-SBJ (NP (DT the) (JJ intrinsic) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN receptor)))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG transmitting) (NP (DT the) (NN PDGFRβ) (NN signal))))) (SBAR-PRP (IN because) (S (NP-SBJ (DT the) (NN truncation) (NN mutation)) (VP (VBZ does) (RB not) (VP (VB exhibit) (NP (NP (DT any) (NN rescue)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NN development)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (DT the) (NN F7) (NN mutant) (NN allele)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ transmits) (ADVP (RB primarily)) (PP-MNR (IN through) (NP (NN kinase) (NN activity))) (-LRB- -LRB-) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG owing) (PP (IN to) (NP (NP (NN loss)) (PP (IN of) (NP (DT the) (ADJP (NP (NN SH2) (NN domain)) (HYPH -) (VBG containing)) (ADJP (NN protein) (HYPH -) (VBG binding)) (NNS sites))))))))))) (-RRB- -RRB-) (VP (RB still) (VP (VBZ supports) (NP (NP (NML (NN v) (HYPH /) (NN p)) (NN development)) (ADJP (JJ sufficient) (PP (IN for) (NP (NN viability))))))))))))))) (. .)) )
( (HEADING (NP (JJ Downstream) (NN Signal) (NN Transduction))) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-1 (NML (NN F2) (, ,) (NN F3) (, ,) (CC and) (NN F5)) (NN mutant) (NNS receptors)) (VP (VBP have) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN studied) (NP-1 (-NONE- *)) (ADVP-MNR (RB biochemically)) (CIT (-LRB- -LRB-) (NNP Valius) (CC and) (NNP Kazlauskas) (CD 1993) (: ;) (NNP Heuchel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN focused) (NP (PRP$ our) (JJ biochemical) (NN analysis)) (PP (IN on) (NP (NP (DT the) (NML (NN F1) (CC and) (NN F7)) (NN mutant) (NNS receptors) (POS ')) (NN signal) (NN transduction))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB verify) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT these) (JJ particular) (NNS mutations))) (PP (IN on) (NP (NML (JJ downstream) (NN signal) (NN transduction)) (NNS cascades))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (NML (NN mouse) (NN embryo)) (NNS fibroblasts)) (-LRB- -LRB-) (NP (NNS MEFs))) (-RRB- -RRB-) (PP-PRP (IN for) (NP (DT these) (NNS analyses))))) (. .)) )
( (S (NP-SBJ (NP (NP (DT All) (NNS lines)) (PP (IN of) (NP (NNS MEFs)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBD generated) (NP-1 (-NONE- *T*)))))) (VP (VBD expressed) (NP (NP (DT the) (NN PDGFRβ)) (NAC-3 (-NONE- *ICH*))) (PP (IN at) (NP (JJ similar) (NNS levels))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 10D)) (-RRB- -RRB-)) (NAC-3 (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN PDGFRα))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (VP (RB not) (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB avoid) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NN PDGFRα))) (PP (IN by) (NP (NN PDGFBB))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD downregulated) (NP (NN PDGFRα) (NN surface) (NN expression)) (PP-MNR (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN PDGFAA))))) (PP-TMP (NP-ADV (CD 2) (NN h)) (IN before) (NP (NN PDGFBB) (NN stimulation)))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (DT all) (NN cell) (NNS lines)) (VP (VBN examined) (NP (-NONE- *))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN tyrosine) (NN phosphorylation)))) (PP-PRP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN ligand))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 10A)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (ADJP (RBS most) (JJ evident)) (JJ phosphorylated) (NNS bands)) (VP (VBP are) (NP-PRD (QP (RB around) (CD 200)) (NN kd)) (, ,) (SBAR-ADV (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (DT the) (NML (NN PDGFRα) (CC and) (NN PDGFRβ))))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN mutated) (NP (QP (CD seven) (IN of) (DT the) (CD 13)) (NNS tyrosines)))))) (, ,) (NP-SBJ-1 (NP (DT a) (JJ significant) (NN amount)) (PP (IN of) (NP (NN phosphorylation)))) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT all) (NN cell) (NNS lines))) (, ,) (PP (IN albeit) (PP-LOC (IN at) (NP (JJR lower) (NNS levels)))) (PP-LOC (IN in) (NP (DT the) (NML (NN F7) (HYPH /) (SYM −)) (NN cell) (NN line))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (CD 10A) (CC and) (CD 10B))) (-RRB- -RRB-)))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NML (JJ whole) (HYPH -) (NN cell)) (NN lysate) (NN phosphotyrosine) (NN blot))) (, ,) (NP-SBJ (NP (DT the) (VBN phosphorylated) (NN protein)) (VP (VBN detected) (NP (-NONE- *)) (PP (IN at) (NP (CD 200) (NNS kd))))) (VP (VBZ is) (ADVP (RB likely)) (NP-PRD (JJ cytoplasmic) (NN PDGFRα)) (, ,) (SBAR-PRP (IN as) (S (NP-SBJ-1 (PRP it)) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN F7) (NNS cells))) (PP-TMP (IN after) (NP (NP (NN downregulation)) (PP (IN of) (NP (DT the) (NN PDGFRα)))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN disrupted) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (DT the) (JJ potential) (ADJP (NN Src) (HYPH -) (VBG binding)) (NNS sites)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Src) (NN activation)))) (ADVP-LOC (RB downstream) (PP (IN of) (NP (PRP$ our) (NN F7) (NN cell) (NN line)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 10B)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TMP (IN Upon) (NP (NN PDGFBB) (NN addition))) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN Src)) (VP (VBN phosphorylated) (NP (-NONE- *)) (PP-LOC (IN on) (NP (NP (NN tyrosine) (CD 418)) (-LRB- -LRB-) (NP (NP (DT a) (NN site)) (SBAR (WHNP-1 (WP$ whose) (NN phosphorylation)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ full) (JJ catalytic) (NN activity)))))))))))))))) (CIT (: ;) (NNP Johnson) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (PP-LOC (IN in) (NP (DT the) (NML (NN F7) (HYPH /) (NN F7)) (NNS MEFs))) (, ,) (NP-SBJ (PRP we)) (VP (VBD did) (RB not) (VP (VB observe) (NP (NP (DT any) (NN increase)) (PP (IN in) (NP (NN Src) (NN activation)))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (JJ other) (NNS reports)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (NN mutation)) (PP-LOC (IN at) (NP (NP (NN amino) (NN acid) (CD 578)) (PP (IN of) (NP (DT the) (NN PDGFRβ)))))) (VP (VBZ is) (ADJP-PRD (JJ sufficient) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG reducing) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Src) (NML (NN binding) (CC and) (NN activation))))))))))))))))))) (CIT (-LRB- -LRB-) (NNP Mori) (FW et) (FW al.) (CD 1993) (: ;) (NNP Twamley) (FW et) (FW al.) (CD 1993) (: ;) (NNP Vaillancourt) (FW et) (FW al.) (CD 1995) (: ;) (NNP Fanger) (FW et) (FW al.) (CD 1997) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (CD Two) (JJ potential) (JJ downstream) (NNS targets)) (PP (IN of) (NP (NN PDGFRβ) (NN activation)))) (VP (VBP are) (NP-PRD (NP (NN activation)) (PP (IN of) (NP (NP (NP (ADJP (NP (JJ extracellular) (NN signal)) (HYPH -) (VBN related)) (NNS kinases) (NML (CD 1) (CC and) (CD 2))) (-LRB- -LRB-) (NP (NN ERK1) (HYPH /) (CD 2))) (-RRB- -RRB-) (CC and) (NP (NN AKT))))) (CIT (-LRB- -LRB-) (NNP Franke) (FW et) (FW al.) (CD 1995) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (S (S (NP-SBJ (NP (NN phosphorylation)) (PP (IN of) (NP (NP (NN ERK1) (HYPH /) (CD 2)) (CC and) (NP (NN AKT))))) (VP (VBZ is) (ADJP-PRD (JJ reduced) (CC or) (JJ absent)) (PP-LOC (IN in) (NP (DT the) (NN F7) (ADJP (JJ homozygous) (CC and) (JJ hemizygous)) (NN mutant) (NN cell) (NNS lines))))) (, ,) (CC but) (S (NP-SBJ (NP (NNS cells)) (VP (VBG expressing) (NP (NP (QP (RB at) (RBS least) (CD one)) (NN copy)) (PP (IN of) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NN receptor)))))) (VP (VBP are) (ADJP-PRD (JJ capable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG inducing) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT these) (JJ downstream) (NNS molecules)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 10C)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (CD seven) (NN tyrosine) (NNS residues))) (PP-LOC (IN on) (NP (DT the) (NN PDGFRβ)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ severe) (NN loss)) (PP (IN of) (NP (JJ downstream) (NN signal) (NN transduction))))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NNS cells)) (VP (VBG bearing) (NP (NP (QP (RB even) (RB just) (CD one)) (NN copy)) (PP (IN of) (NP (DT the) (NN F1) (NN receptor)))))) (VP (VBP show) (NP (NP (VBN increased) (NN phosphorylation)) (PP (IN of) (NP (NN ERK1) (HYPH /) (CD 2))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (NN concordance)) (PP (IN with) (NP (NP (DT the) (ADJP (FW in) (FW vivo)) (NNS data)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NP (NN lack)) (PP (IN of) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site))) (PP-LOC (IN on) (NP (DT the) (NN receptor)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ downstream) (NN signaling) (NNS events)))) (CC and) (NP (NP (DT a) (JJ subsequent) (NN increase)) (PP (IN in) (NP (NN v) (HYPH /) (NN p))))))))))))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (DT the) (NN F1) (NN mutant) (NN receptor)) (VP (VBZ has) (NP (VBN increased) (NN activity)) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (NN F7) (NNS receptors)) (VP (VBP have) (NP (NP (VBN decreased) (NN activation)) (PP (IN of) (NP (DT these) (JJ same) (NNS pathways)))) (, ,) (PP (IN despite) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG having) (NP (NP (ADJP (RB apparently) (JJ normal)) (NNS levels)) (PP (IN of) (NP (NN kinase) (NN activity))))))))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (NML (NN RTK) (NN signal)) (NN transduction)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG directing) (NP (JJ many) (JJ cellular) (NNS activities)))))) (. .)) )
( (S (NP-SBJ-2 (PRP We)) (VP (VBP have) (VP (VBN used) (NP (DT an) (ADJP (FW in) (FW vivo)) (NN system)) (S-PRP (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB analyze) (SBAR (WHADVP-1 (WRB how)) (S (NP-SBJ (JJ cellular) (NN development)) (VP (VBZ relates) (PP (IN to) (NP (DT the) (NN signaling) (NNS pathways))) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT the) (NN PDGFRβ)))) (ADVP-MNR-1 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Examination)) (PP (IN of) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN population)))) (VP (VBZ demonstrates) (NP (DT a) (JJ quantitative) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN extent)) (SBAR (WHADVP-3 (IN that)) (S (NP-SBJ-1 (NNS signals)) (VP (VBP are) (VP (VBG being) (VP (VBN transduced) (NP-1 (-NONE- *)) (ADVP-3 (-NONE- *T*)))))))) (CC and) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN v) (HYPH /) (NN p)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP form)))))))) (. .)) )
( (S (NP-SBJ (JJ Several) (JJ other) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NNS combinations)) (PP (IN of) (NP (NN signal) (NN transduction) (NNS pathways)))) (VP (MD may) (VP (VB dictate) (NP (JJ cellular) (NNS outcomes)))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Examples)) (PP (IN of) (NP (DT these)))) (VP (VBP are) (NP-PRD (NP (NP (NML (NN T) (NN cell)) (NN development)) (PP-LOC (IN in) (NP (DT the) (JJ immune) (NN system)))) (CC and) (NP (NP (NNS gradients)) (PP (IN of) (NP (NNS morphogens))) (PP-LOC (IN in) (NP (JJ developmental) (NNS systems))))) (CIT (-LRB- -LRB-) (NNP Heemskerk) (CC and) (NNP DiNardo) (CD 1994) (: ;) (NNP Nellen) (FW et) (FW al.) (CD 1996) (: ;) (NNP Zecca) (FW et) (FW al.) (CD 1996) (: ;) (NNP Ferrell) (CC and) (NNP Machleder) (CD 1998) (: ;) (NNP Gong) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (PP-LOC (IN In) (NP (PRP$ our) (NN system))) (, ,) (NP-SBJ-1 (DT the) (NN signal)) (VP (MD can) (VP (VB be) (VP (VBN affected) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (CD two) (NNS ways)))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ first)) (VP (VBZ is) (PP-MNR-PRD (IN by) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN receptor)) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (NN cell) (NN surface))))))))) (. .)) )
( (S (NP-SBJ (NML (NN V) (HYPH /) (NN p)) (NNS numbers)) (VP (VBP are) (ADJP-PRD (RB significantly) (JJR lower)) (PP-LOC (IN in) (NP (NML (NN PDGFRβ+) (HYPH /) (SYM −)) (NNS embryos))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS controls))) (ADVP-TMP-2 (-NONE- *T*)))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN situation))) (S (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ overall) (NN signal)))))) (, ,) (CC but) (S (NP-SBJ-1 (DT no) (JJ specific) (, ,) (ADJP (RB directly) (VBN associated)) (NN pathway)) (VP (VBZ is) (VP (VBN disrupted) (NP-1 (-NONE- *)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ demonstrates) (NP (NP (DT a) (JJ quantitative) (NN role)) (PP (IN for) (NP (NN receptor) (NN activity))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ second) (NN influence)) (PP (IN on) (NP (NN PDGFRβ) (NN signal) (NN transmission)))) (VP (VBZ is) (PP-PRD (IN by) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ associated) (NN SH2) (ADJP (NN domain) (HYPH -) (VBG containing)) (NN proteins)))))) (. .)) )
( (S (S (NP-SBJ (NP (NN Loss)) (PP (IN of) (NP (RB even) (DT a) (JJ single) (NN pathway)))) (VP (VBZ results) (PP (IN in) (NP (NP (NN reduction)) (PP (IN of) (NP (NN v) (HYPH /) (NN p))))))) (, ,) (CC and) (S (SBAR-ADV (IN as) (S (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (VBN disrupted) (NNS pathways)))) (VP (VBZ increases)))) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ concomitant) (NN decrease)) (PP (IN in) (NP (NN v) (HYPH /) (NN p)))))) (. .)) )
( (S (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (DT no) (JJ significant) (NN difference)) (PP (IN between) (NP (NP (DT the) (NN F2) (NML-3 (-NONE- *RNR*))) (CC and) (NP (DT the) (NN F3) (NML-3 (-NONE- *RNR*))) (NML-3 (NN mutant) (NNS alleles)))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (DT a) (JJ noticeable) (NN difference)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (NP (DT the) (NN number)) (PP (IN of) (NP (NNS mutations)))) (VP (VBZ is) (ADVP (RBR further)) (VP (VBN increased) (NP-1 (-NONE- *)) (ADVP-TMP-2 (-NONE- *T*)))))))) (. .)) )
( (S (NP-SBJ-2 (DT These) (VBG signaling) (NNS differences)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN illustrated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NN v) (HYPH /) (NN p)) (NN number)) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ vascular) (NNS pathologies))))))))) (VP (MD can) (VP (VB be) (VP (VBN categorized) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN mutant) (NNS alleles))) (PP-MNR (IN by) (NP (NP (DT the) (JJ following) (NN hierarchy)) (: :) (NP (NP (NN F1)) (ADJP (SYM >) (NP (NP (JJ wild) (HYPH -) (NN type)) (ADJP (SYM >) (NP (NP (NN F2)) (ADJP (SYM =) (NP (NP (NN F3)) (ADJP (SYM >) (NP (NP (NN F5)) (ADJP (SYM >) (NP (NP (NN F7)) (ADJP (SYM >) (NP (NN null))))))))))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NNS hemizygotes)) (VP (VBP show) (NP (NP (DT an) (ADJP (RB even) (JJ further)) (NN reduction)) (PP (IN in) (NP (NN v) (HYPH /) (NN p)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NML (NN F) (NN series)) (NNS homozygotes))) (ADVP-2 (-NONE- *T*)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (JJ specific) (NN effector) (NNS pathways)) (VP (MD may) (VP (VB play) (NP (NP (JJR more)) (PP (IN of) (NP (DT a) (NN role)))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (RB fine) (HYPH -) (VBG tuning) (NP (NN PDGFRβ) (NNS signals)))))))))) (. .)) )
( (S (PP (IN In) (ADJP (JJ total))) (, ,) (NP-SBJ (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-1 (NN PDGFRβ) (NN signal) (NN transduction)) (VP (VBZ is) (VP (VBN regulated) (NP-1 (-NONE- *)) (PP (CONJP (RB not) (RB only)) (PP (IN by) (NP-LGS (NP (JJ direct) (NN binding)) (PP (IN of) (NP (NN signal) (NN transduction) (NNS molecules))))) (, ,) (CONJP (CC but) (RB also)) (PP (IN by) (NP-LGS (NN receptor) (NN expression) (NNS levels)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB possibly)) (VP (VBG reflecting) (NP (JJ inherent) (NN kinase) (NN activity))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-2 (NP (DT no) (JJ particular) (VBG signaling) (NN pathway)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN analyzed) (NP-1 (-NONE- *T*))))))) (VP (VBZ is) (ADVP (RB absolutely)) (VP (VBN required) (NP-2 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN transmission)) (PP (IN of) (NP (NN PDGFRβ) (NNS signals))))) (, ,) (SBAR-PRP (IN because) (S (NP-SBJ (RB even) (DT the) (NN F7) (NN allele)) (VP (VBZ has) (NP (NP (DT a) (NN phenotype)) (ADJP (ADJP (RBR less) (JJ severe)) (PP (IN than) (NP (DT the) (NN null)))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP-SBJ (NP (NN receptor) (NNS levels)) (CC and) (NP (NN kinase) (NN activity))) (VP (MD may) (VP (VB have) (NP (DT a) (JJ direct) (NN role)) (PP (IN in) (NP (NN signal) (NN transduction))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN observed) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ chimeric) (NN PDGFR)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ has) (NP (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN PDGFRβ)))) (CC but) (NP (NP (DT the) (JJ intracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN PDGFRα))))))))) (VP (VBZ exhibits) (NP (NP (DT a) (ADJP (RBR more) (JJ severe)) (NN phenotype)) (PP (IN than) (NP (DT the) (NN F5) (NN allele))))))) (CIT (-LRB- -LRB-) (NNP Klinghoffer) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This) (JJ chimeric) (NN receptor)) (VP (MD can) (VP (VB signal) (PP-MNR (IN through) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (JJ same) (JJ downstream) (NNS components)) (PP (IN as) (NP (DT the) (NN PDGFRβ))))) (PP (IN except) (PP (IN for) (NP (NN RasGAP)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (RBR more) (JJ severe)) (JJ vascular) (NNS defects)) (PP-LOC (IN in) (NP (DT these) (NML (JJ chimeric) (NN receptor)) (NNS mice)))) (VP (MD may) (VP (VB be) (PP-PRD (IN due) (IN to) (NP (NP (JJ reduced) (NML (NML (NN kinase) (NN activity)) (CONJP (CC and) (HYPH /) (CC or)) (NML (NN expression) (NNS levels)))) (PP (IN of) (NP (DT the) (JJ chimeric) (NN receptor))))))))))))) (. .)) )
( (S (S (NP-SBJ-4 (NP (DT The) (NN PDGFRβ) (POS 's)) (NN signaling) (NNS pathways)) (VP (VBZ appears) (S (NP-SBJ-4 (-NONE- *)) (VP (TO to) (VP (VB dictate) (NP (NP (DT the) (JJ absolute) (NNS numbers)) (PP (IN of) (NP (NP (NN v) (HYPH /) (NN p)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP form)))))))))))) (, ,) (CC but) (S (SBAR-NOM-SBJ-3 (WHADVP-2 (WRB how)) (S (NP-SBJ (DT the) (JJ individual) (NNS pathways)) (VP (VBP contribute) (PP (IN to) (NP (DT this) (NN phenotype))) (ADVP-2 (-NONE- *T*))))) (VP (VBZ remains) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN tested) (NP-3 (-NONE- *)))))))) (. .)) )
( (S (PP (IN In) (NP (NN fact))) (, ,) (NP-SBJ-1 (NP (ADJP (RB very) (JJ little)) (NN difference)) (PP (IN in) (NP (NP (NNS numbers)) (PP (IN of) (NP (NN v) (HYPH /) (NN p)))))) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN between) (NP (NP (DT the) (NN F2) (NML-3 (-NONE- *RNR*))) (CC and) (NP (DT the) (NN F3) (NML-3 (-NONE- *RNR*))) (NML-3 (NNS mutants)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN PLCγ) (NNS signals)) (VP (MD may) (VP (VB be) (ADVP (RB somehow)) (ADJP-PRD (ADJP (JJ redundant) (PP (IN with) (NP-2 (-NONE- *RNR*)))) (CC or) (ADJP (JJ dependent) (PP (IN on) (NP-2 (-NONE- *RNR*)))) (NP-2 (DT the) (NN PI3K) (NN pathway))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (JJ additional) (NNS pathways)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT an) (JJ incremental) (NN loss)) (PP (IN of) (NP (NN v) (HYPH /) (NN p)))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN difference)) (PP (IN between) (NP (NP (DT the) (NN F3) (NML-2 (-NONE- *RNR*))) (CC and) (NP (DT the) (NN F5) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS mutations))))) (VP (VBZ is) (NP-PRD (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB bind) (NP (NP (NN SHP) (HYPH -) (CD 2)) (CC and) (NP (NN RasGAP))))))))) (, ,) (CC and) (S (NP-SBJ-3 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (NP-3 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT both)) (PP (IN of) (NP (DT these) (NNS molecules)))) (VP (VBP play) (NP (NNS roles)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG downregulating) (NP (DT the) (NN PDGFRβ) (NN signal)))))))) (CIT (-LRB- -LRB-) (NNP Klinghoffer) (CC and) (NNP Kazlauskas) (CD 1995) (: ;) (NNP Ekman) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT these) (NN signaling) (NNS pathways)))) (VP (VBZ is) (ADJP-PRD (JJ detrimental) (PP (IN to) (NP (NN PDGFRβ) (NN signal) (NN transduction))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (DT both)) (VP (MD may) (VP (VB have) (NP (ADJP (JJ positive) (CC and) (JJ negative)) (NNS influences)) (PP (IN on) (NP (NN receptor) (NN activity))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBP are) (NP-PRD (NP (JJ several) (JJ potential) (NNS ways)) (SBAR (WHADVP-1 (WRB that)) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT these) (NN signaling) (NNS pathways)))) (VP (VBZ leads) (PP (IN to) (NP (NML (NN v) (HYPH /) (NN p)) (NN reduction))) (ADVP-MNR-1 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ (CD One) (NN mechanism)) (VP (MD would) (VP (VB be) (SBAR-PRD (IN that) (S (NP-SBJ (DT each) (NN pathway)) (VP (VBZ contributes) (PP (IN to) (NP (DT a) (JJ specific) (JJ cellular) (NN outcome)))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (NN SFK) (POS 's)) (JJ predominant) (NN role)) (VP (MD could) (VP (VB be) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB promote) (NP (NN proliferation)) (CIT (-LRB- -LRB-) (NNP Roche) (FW et) (FW al.) (CD 1995) (: ;) (NNP Hansen) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (NN PI3K) (NN activity)) (VP (MD could) (VP (VB be) (ADJP-PRD (RBR more) (JJ important)) (PP (IN for) (NP (NN migration))) (CIT (-LRB- -LRB-) (NNP Kundra) (FW et) (FW al.) (CD 1994) (: ;) (NNP Wennstrom) (FW et) (FW al.) (CD 1994b) (-RRB- -RRB-)))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NP (DT the) (JJ combined) (NN loss)) (PP (IN of) (NP (DT these) (NNS pathways)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ net) (NN reduction)) (PP (IN in) (NP (NN v) (HYPH /) (NN p))))) (, ,) (PP (IN albeit) (PP (IN for) (NP (ADJP (RB entirely) (JJ different)) (JJ cellular) (NNS reasons))))) (. .)) )
( (S (NP-SBJ (DT A) (JJ second) (NN scenario)) (VP (MD would) (VP (VB be) (SBAR-PRD (IN that) (S (NP-SBJ (DT all) (NNS pathways)) (VP (VBP lead) (PP (IN to) (NP (DT a) (ADJP (JJ single) (CC or) (JJ few)) (JJ specific) (JJ cellular) (NNS conclusions)))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT any) (CD one) (NN pathway)))) (VP (VP (ADVP (RB only)) (VBZ reduces) (NP (DT the) (NN outcome))) (CC but) (VP (VBZ does) (RB not) (VP (VB ablate) (NP (PRP it))))) (. .)) )
( (S (NP-SBJ (NP (NN Evidence)) (PP (IN from) (NP (ADJP (JJ immediate) (HYPH -) (JJ early)) (NML (NN gene) (NN expression)) (NN analysis)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT this) (NN mechanism)) (VP (MD may) (VP (VB occur) (CIT (-LRB- -LRB-) (NNP Fambrough) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT this) (NN possibility)) (VP (VBZ does) (RB not) (VP (VB require) (SBAR (IN that) (S (NP-SBJ (DT all) (NNS pathways)) (VP (VBP contribute) (ADVP (RB equally)))))))))))))) (. .)) )
( (S (ADVP (RB Last)) (, ,) (NP-SBJ (DT some) (NNS pathways)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ primary) (NN role)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT the) (NN receptor)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NNS others)) (VP (MD may) (VP (VB be) (ADJP-PRD (RBR more) (JJ secondary)))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN PI3K)) (VP (MD may) (VP (VB be) (NP-PRD (DT a) (JJ principal) (NN pathway)) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (JJ other) (NNS pathways)) (VP (MD may) (VP (VB be) (ADJP-PRD (RBR less) (JJ significant))))))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NML (NN F2) (HYPH /) (NN F2)) (NN mutant) (NNS mice)) (VP (VBP have) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NNS numbers)))) (SBAR-ADV (WHADVP-3 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NML-4 (-NONE- *RNR*))) (CC and) (NP (DT the) (JJ heterozygous) (NML-4 (-NONE- *RNR*))) (NML-4 (NNS mice)))) (ADVP-TMP-3 (-NONE- *T*))))))) (, ,) (CC and) (S (NP-SBJ (JJ additional) (NNS mutations)) (VP (VBP have) (NP (NP (JJR less)) (PP (IN of) (NP (NP (DT an) (NN effect)) (PP-2 (-NONE- *ICH*)))) (PP (IN than) (NP (NN PI3K))) (PP-2 (IN on) (NP (NML (NN v) (HYPH /) (NN p)) (NNS numbers)))))) (. .)) )
( (S (S (NP-SBJ-1 (DT A) (JJ similar) (NN situation)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN with) (NP (DT the) (NN PDGFRα))) (CIT (-LRB- -LRB-) (NNP Klinghoffer) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))))) (: :) (S (NP-SBJ (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NP (NN mouse) (NNS embryos)) (PP (IN with) (NP (NP (NN loss)) (PP (IN of) (NP (DT the) (NML (NN PDGFRα) (HYPH –) (NN PI3K)) (NN pathway)))))))) (VP (VBD was) (ADJP-PRD (ADJP (RB just) (RB as) (JJ severe)) (PP (IN as) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNS embryos)) (VP (VBG expressing) (NP (NP (DT a) (NN PDGFRα) (NN F7) (NN allele)) (-LRB- -LRB-) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (DT the) (NN F7) (NN allele)) (PP (IN of) (NP (DT the) (NN PDGFRβ)))))))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ pathological) (NN difference)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN between) (NP (NP (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS alleles)) (CC versus) (NP (NP (DT all)) (PP (IN of) (NP (DT the) (JJ other) (NNS mutations)))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (NN SHP) (HYPH -) (CD 2)) (, ,) (NP (NN SFK)) (, ,) (NP (NN Grb2)) (, ,) (CC and) (NP (NN RasGAP))) (ADVP (RB also)) (VP (VBP impact) (NP (NN pericyte) (NN development)))))) (. .)) )
( (S (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*)) (VP (VBG Assessing) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (DT these) (NNS pathways)))))) (VP (MD would) (VP (VB require) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG generating) (NP (NP (JJ additional) (NNS alleles)) (PP (IN with) (NP (NP (JJ different) (NNS combinations)) (PP (IN of) (NP (NN mutant) (NNS sites)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ only) (NN signaling) (NNS differences)) (PP (IN between) (NP (NP (DT the) (NN F3) (NN mutation)) (CC and) (NP (DT the) (NN F5) (NN mutation))))) (VP (VBP are) (NP-PRD (DT the) (NML (NML (NN SHP) (HYPH -) (CD 2)) (CC and) (NML (NN RasGAP))) (NNS pathways))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (CD one) (CC or) (DT both)) (PP (IN of) (NP (DT these) (NNS pathways)))) (VP (VBP promote) (NP (NN PDGFRβ) (NN signaling))))) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN to) (NP (DT the) (NN F1) (NN mutation))))) (, ,) (SBAR-ADV (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP-SBJ (NP (NN absence)) (PP (IN of) (NP (NN RasGAP)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (JJ potential) (NN increase)) (PP (IN of) (NP (NN PDGFRβ) (NN signaling)))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (JJ apparent) (NN contradiction)) (VP (MD may) (VP (VB indicate) (SBAR (SBAR (IN that) (S (NP-SBJ (NN RasGAP)) (VP (VBZ plays) (NP (NP (CC both) (NP (DT a) (JJ positive) (NML-1 (-NONE- *RNR*))) (CC and) (NP (DT a) (JJ negative) (NML-1 (-NONE- *RNR*))) (NML-1 (NN role))) (PP (IN in) (NP (NN signal) (NN transduction))))))) (CC or) (SBAR (IN that) (S (NP-SBJ (NN SHP) (HYPH -) (CD 2)) (VP (MD may) (VP (VB have) (NP (NP (ADVP (RB mainly)) (DT a) (JJ positive) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG modulating) (NP (DT this) (NN response))))))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (PRP we)) (VP (VBP find) (SBAR (IN that) (S (NP-SBJ (NP (JJ overall) (NN loss)) (PP (IN of) (NP (JJ downstream) (NNS pathways)))) (VP (VBZ attenuates) (NP (NN receptor) (NNS actions)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN demonstrated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NN v) (HYPH /) (NN p)) (NN formation)))))))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ surprising)) (SBAR-2 (IN that) (S (NP-SBJ (DT the) (NML (NN F7) (HYPH /) (NN F7)) (NNS mice)) (VP (VBP do) (RB not) (VP (VB phenocopy) (NP (DT the) (JJ null) (NNS animals))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN F7) (NN allele)) (VP (VBZ possesses) (NP (NNS disruptions)) (PP-LOC (IN at) (NP (QP (CD seven) (IN of) (DT the) (CD 13)) (JJ known) (NML (VBN phosphorylated) (NN tyrosine)) (NNS residues)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS mutations)) (VP (MD should) (VP (VB disrupt) (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (NP (DT the) (NML (NN signal) (NN relay)) (NNS molecules)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT the) (NN receptor))))))))) (. .)) )
( (S (NP-SBJ (DT The) (VBG remaining) (NNS tyrosines)) (VP (VBP are) (ADJP-PRD (JJ capable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG binding) (NP (NNS SFKs) (, ,) (NNS STATs) (, ,) (CC and) (NNS Grbs))))))) (. .)) )
( (S (S (PP (VBN Based) (PP (IN on) (NP (JJ several) (JJ previous) (NNS reports)))) (, ,) (NP-SBJ (NP (NN disruption)) (PP (IN of) (NP (NN Y578)))) (VP (VBZ affects) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NN SFK) (NN binding)))) (CIT (-LRB- -LRB-) (NNP Mori) (FW et) (FW al.) (CD 1993) (: ;) (NNP Twamley) (FW et) (FW al.) (CD 1993) (: ;) (NNP Vaillancourt) (FW et) (FW al.) (CD 1995) (: ;) (NNP Fanger) (FW et) (FW al.) (CD 1997) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NNS SFKs)) (VP (VBP do) (RB not) (VP (VB become) (ADJP-PRD (JJ activated)) (PP-TMP (IN after) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NN F7) (NN receptor)))))))))))) (. .)) )
( (S (PP (IN As) (PP (IN for) (NP (NP (NP (DT the) (NN signaling) (NNS roles)) (PP (IN of) (NP (NN STAT) (CC and) (NN Grb2)))) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN receptor))))))) (, ,) (NP-SBJ-1 (JJ little) (JJ direct) (NN function)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT these) (VBG remaining) (NN effector) (NNS molecules))) (PP (IN in) (NP (ADJP (NN PDGF) (HYPH -) (VBN induced)) (JJ cellular) (NNS responses))) (CIT (-LRB- -LRB-) (NNP Heldin) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NN F7) (NN signal) (NN transmission)) (VP (MD must) (VP (VB use) (NP (NP (DT some) (JJ other) (NNS means)) (PP (IN than) (NP (NP (JJ direct) (NN binding)) (PP (IN by) (NP (ADJP (NP (NN SH2) (NN domain)) (HYPH -) (VBG containing)) (NN proteins)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN receptor)) (VP (MD should) (ADVP-TMP (RB still)) (VP (VB have) (NP (JJ full) (NN kinase) (NN activity)) (, ,) (PP (IN unlike) (NP (NP (DT the) (JJ lethal) (NN βT) (NN mutation)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBG lacking) (NP (NP (NN half)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN domain)) (CC and) (NP (DT the) (ADJP (NP (NP (NN SHP) (HYPH -) (CD 2)) (HYPH -) (CC and) (NP (NN PLCγ))) (HYPH -) (VBG binding)) (NNS sites))))))))))))) (. .)) )
( (S (ADVP (RB Possibly)) (, ,) (NP-SBJ (DT the) (NN receptor)) (VP (VBZ is) (NP-PRD (NP (VBG phosphorylating) (NNS molecules)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADVP (RB only) (RB transiently)) (VP (VBN associated) (NP-1 (-NONE- *)))))))) (. .)) )
( (S (NP-SBJ (DT Another) (NN possibility)) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ (JJ other) (NNS receptors)) (VP (MD may) (VP (VB function) (PP (IN as) (NP (NNS surrogates)))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (ADJP (RBS most) (JJ likely)) (NN surrogate)) (VP (VBZ is) (NP-PRD (DT the) (NN PDGFRα)))) (, ,) (CC but) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (PP-LOC (IN in) (NP (NP (JJ several)) (PP (IN of) (NP (DT the) (NML (NML (NN v) (HYPH /) (NN p)) (NN cell)) (NNS populations))))) (NP-SBJ-1 (DT the) (NN PDGFRα)) (VP (VBZ is) (RB not) (VP (VBN expressed) (NP-1 (-NONE- *))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Other) (NN candidate) (NNS molecules)) (PP (IN for) (NP (PDT such) (DT a) (NN mechanism)))) (VP (VBP are) (NP-PRD (NP (NNS integrins)) (, ,) (NP (NNS ephrins)) (, ,) (CC and) (NP (DT the) (NML (JJ low) (HYPH -) (NN density)) (ADJP (NP (NN lipoprotein) (NN receptor)) (HYPH -) (VBN related)) (NN protein) (NN LRP))) (CIT (-LRB- -LRB-) (NNP Miyamoto) (FW et) (FW al.) (CD 1996) (: ;) (NNP Schneller) (FW et) (FW al.) (CD 1997) (: ;) (NNP Woodard) (FW et) (FW al.) (CD 1998) (: ;) (NNP Boucher) (FW et) (FW al.) (CD 2002) (: ;) (NNP Loukinova) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (DT these) (NN proteins)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB cross-talk) (PP (IN with) (NP (DT the) (NN PDGFRβ)))))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ unclear)) (SBAR-2 (IN whether) (S (NP-SBJ-3 (PRP they)) (VP (VBP have) (NP (DT the) (NN capability) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB substitute) (PP (IN for) (NP (NP (DT the) (NN PDGFRβ) (POS 's)) (JJ own) (NN signaling) (NNS components))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN F1) (NN mutant) (NN allele)) (VP (VBZ is) (NP-PRD (NP (DT an) (JJ interesting) (NN corollary)) (PP (IN to) (NP (DT the) (NML (NN F) (NN mutant)) (NN series))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (DT all)) (PP (IN of) (NP (DT the) (JJ other) (NNS mutations)))) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB have) (NP (DT a) (JJ detrimental) (NN effect)) (PP (IN on) (NP (NN PDGFRβ) (NN signal) (NN transduction))))))))) (, ,) (NP-SBJ (DT the) (NN F1) (NN mutation)) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (JJ apparent) (NN increase)) (PP (IN in) (NP (NN PDGFRβ) (NN activity))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN determined) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NN v) (HYPH /) (NN p)) (NN incidence))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (JJ previous) (NNS observations) (SBAR (IN that) (S (NP-SBJ (NN RasGAP) (NN function)) (VP (VBZ decreases) (NP (DT the) (NML (NN Ras) (HYPH /) (NN MAP)) (NML (NN kinase) (NN pathway)) (NML (NN activity) (CC and) (NN migration)))))))))) (CIT (-LRB- -LRB-) (NNP Kundra) (FW et) (FW al.) (CD 1994) (: ;) (NNP Ekman) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT an) (ADJP (VB add) (HYPH -) (RP back)) (NN mutation)) (PP (IN of) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site)))) (VP (VBD induced) (NP (NP (DT a) (JJ different) (NN gene) (NN profile)) (PP (IN from) (NP (DT the) (NN PDGFRβ) (ADJP (JJ immediate) (HYPH -) (JJ early)) (NN gene) (NN profile)))) (CIT (-LRB- -LRB-) (NNP Fambrough) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NN RasGAP)) (VP (MD may) (VP (VB have) (NP (NP (JJ different) (NN signaling) (NNS capabilities)) (PP (IN from) (NP (DT the) (JJ other) (NML (NN PDGFRβ) (NN signal) (NN transduction)) (NNS components))))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN mutant) (NNS mice)) (CONJP (RB not) (RB only)) (VP (VB uncover) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN RTK) (NN signal) (NN transduction))) (ADVP-LOC (FW in) (FW vivo))))) (, ,) (CC but) (S (NP-SBJ (PRP they)) (ADVP (RB also)) (VP (VBP reveal) (NP (NP (DT some) (JJ interesting) (NN information)) (PP (VBG regarding) (NP (NML (NN v) (HYPH /) (NN p)) (NN cell) (NN development)))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-4 (NML (NN v) (HYPH /) (NN p)) (NN cell) (NN development)) (VP (VBZ is) (VP (VBN impaired) (NP-4 (-NONE- *)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (NN PDGFRβ) (NN signal) (NN transduction)) (VP (VBZ is) (VP (VBN disrupted) (NP-1 (-NONE- *)) (ADVP-TMP-2 (-NONE- *T*)))))))))) (, ,) (NP-SBJ (NP (DT a) (JJ basal) (NN level)) (PP (IN of) (NP (NNS cells)))) (VP (VBZ forms) (, ,) (PP (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (JJ previous) (NNS observations) (SBAR (IN that) (S (NP-SBJ-3 (NP (NN propagation) (, ,) (CC not) (NN initiation)) (, ,) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NN cell) (NN development)))) (VP (VBZ is) (VP (VBN directed) (NP-3 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN PDGFRβ))) (CIT (-LRB- -LRB-) (NNP Lindahl) (FW et) (FW al.) (CD 1997a) (: ;) (NNP Hellström) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-))))))))))) (. .)) )
( (S (PP-LOC (ADVP (RB Even)) (IN in) (NP (DT the) (JJ null) (NNS embryos))) (, ,) (NP-SBJ-1 (NML (NN v) (HYPH /) (NN p)) (NNS cells)) (VP (MD can) (VP (VB be) (VP (VBN found) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-3 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (NP-3 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ-2 (NN PDGFRβ) (NNS signals)) (VP (VBP are) (VP (VBN required) (NP-2 (-NONE- *)) (PP-PRP (IN for) (NP (NP (DT the) (NN expansion)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))))) (CIT (-LRB- -LRB-) (NNP Lindahl) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (DT this)) (VP (MD may) (VP (VB be) (NP-PRD (DT the) (NN case)))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ curious)) (SBAR-1 (IN that) (S (PP-LOC (IN in) (NP (DT the) (NML (NN F5) (CC and) (NN F7)) (NNS animals))) (, ,) (NP-SBJ (DT the) (NN pericyte) (NNS numbers)) (ADVP-TMP (RB never)) (VP (VBP reach) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS levels)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (JJ vascular) (NNS pathologies))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBP are) (NP-PRD (NP (CD two) (NNS explanations)) (PP (IN for) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP-SBJ (NML (NN v) (HYPH /) (NN p)) (NNS cells)) (ADVP-TMP (RB never)) (VP (VBP reach) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS levels))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ first)) (VP (VBZ is) (SBAR-PRD (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (JJ constant) (NN turnover)) (PP (IN in) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN population)))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN rate)) (PP (IN of) (NP (NN replacement))) (PP-LOC (IN in) (NP (DT the) (NN mutant) (NNS mice)))) (VP (VBZ is) (PP-PRD (IN below) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN loss))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ net) (NN reduction)) (PP (IN in) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN population)))))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Evidence)) (PP (IN against) (NP (DT this) (NN mechanism)))) (VP (VBZ is) (NP-PRD (DT the) (NN failure) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB observe) (NP (NP (NP (DT any) (JJ significant) (NN proliferation)) (PP-LOC (IN in) (NP (DT the) (JJ adult) (NML (JJ wild) (HYPH -) (NN type)) (NNS animals))) (PP (IN under) (NP (JJ normal) (NNS conditions)))) (CC or) (NP (NP (JJ significant) (NN apoptosis)) (PP-LOC (IN in) (NP (NP (DT the) (NN mutant) (NN panel)) (PP (IN of) (NP (NNS mice))))))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (JJ second) (NN possibility)) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (DT a) (JJ specific) (NN window)) (PP-TMP (IN during) (NP (NN development))) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (NML (NN v) (HYPH /) (NN p)) (NNS cells)) (VP (MD can) (VP (VB expand) (ADVP-TMP-1 (-NONE- *T*)))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (DT a) (JJ specified) (NN time))) (, ,) (NP-SBJ-1 (NML (NML (NML (NN v) (HYPH /) (NN p)) (NN cell)) (NN number)) (NN expansion)) (VP (MD could) (VP (VB be) (VP (VBN limited) (NP-1 (-NONE- *)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB perhaps)) (ADJP-PRD (JJ related) (PP (IN to) (NP (NP (NP (DT the) (NN ability)) (S-3 (-NONE- *ICH*))) (PP (IN of) (NP (JJ endothelial) (NNS cells))) (S-3 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (DT the) (NN PDGF) (NN ligand))))))))) (CIT (-LRB- -LRB-) (NNP Benjamin) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (NN Support)) (PP (IN for) (NP (DT this) (NN model)))) (VP (VBZ is) (NP-PRD (NP (DT the) (NN inability) (S-1 (-NONE- *ICH*))) (PP (IN of) (NP (JJ nascent) (JJ endothelial) (NNS tubes))) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB recruit) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)) (PP-LOC (IN in) (NP (NNS tumors))))))) (CIT (-LRB- -LRB-) (NNP Abramsson) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN inability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB develop) (NP (NP (JJ sufficient) (NNS numbers)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)))))))) (ADVP (RB also)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN recapitulated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN eye) (NN vasculature))))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN maturation)) (PP (IN of) (NP (DT the) (NN vessel)))) (VP (VBZ is) (ADJP-PRD (ADJP (RBR more) (JJ dependent) (PP (IN on) (NP (DT the) (JJ local) (NN environment)))) (PP (IN than) (PP (IN on) (NP (NP (DT the) (JJ chronological) (NN age)) (PP (IN of) (NP (DT the) (NN embryo))))))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN combination)) (PP (IN of) (NP (NN signaling) (NNS pathways))) (ADVP (RB downstream) (PP (IN of) (NP (NN PDGFRβ))))) (VP (VBZ determines) (NP (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells)))))))) (. .)) )
( (S (NP-SBJ-1 (DT These)) (VP (MD can) (VP (VB be) (VP (VBN modulated) (NP-1 (-NONE- *)) (PP (CONJP (RB not) (RB only)) (PP (IN by) (NP-LGS (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN receptor)) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (NN cell) (NN surface)))))))) (, ,) (CONJP (CC but) (RB also)) (PP (IN by) (NP-LGS (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ specific) (JJ downstream) (NN signaling) (NNS pathways)) (VP (VBN activated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN receptor)))))))))))) (. .)) )
( (S (NP-SBJ (SBAR-NOM (IN Whether) (S (NP-SBJ (DT these) (NNS results)) (VP (VBP are) (ADJP-PRD (JJ unique) (PP (IN to) (NP (NP (NN PDGFRβ) (NN signal) (NN transduction)) (PP-LOC (IN in) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))))))))) (CC or) (SBAR-NOM (IN whether) (S (NP-SBJ-1 (PRP they)) (VP (MD can) (VP (VB be) (VP (VBN extrapolated) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ other) (NN RTK))))))))) (VP (VBZ remains) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN demonstrated) (NP-2 (-NONE- *))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NNS Mice))) )
( (S (NP-SBJ-2 (NP (NN Point) (NNS mutations)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP disrupt) (NP (DT the) (JJ designated) (NML (NN signal) (NN transduction)) (NNS pathways)))))) (VP (VBD were) (VP (VBN generated) (NP-2 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG changing) (NP (DT the) (NN tyrosine) (NN residue)) (PP (IN to) (NP (NN phenylalanine)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN exception)) (VP (VBD was) (NP-PRD (NP (NN Y1020)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN mutated) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB encode) (NP (DT an) (NN isoleucine))))) (, ,) (S-ADV (ADVP (RB thus)) (NP-SBJ (-NONE- *PRO*)) (VP (VBG generating) (NP (NP (DT a) (JJ unique) (NN restriction) (NN site)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD facilitated) (NP (NP (NN identification)) (PP (IN of) (NP (JJ homologous) (NNS recombinants)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Mouse) (NNS mutants) (NML (NN F2) (CC and) (NN F3))) (VP (VBP have) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Heuchel) (FW et) (FW al.) (CD 1999) (: ;) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN targeting) (NN vector)) (PP (IN for) (NP (DT the) (NML (NN F1) (, ,) (NN F5) (, ,) (CC and) (NN βT)) (NNS mutations)))) (VP (VBD utilized) (NP (NP (DT the) (JJ same) (NNS arms)) (PP (IN of) (NP (NN homology))) (PP (IN as) (NP (DT the) (NN F3) (NN vector))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS exons)) (VP (VBG containing) (NP (DT the) (NN point) (NNS mutations)))) (VP (VBD were) (VP (VP (VBN introduced) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NNS arms)) (PP (IN of) (NP (NP (NN homology)) (PP (IN of) (NP (DT the) (NN targeting) (NN vector))))))) (PP-MNR (IN by) (NP (ADJP (NN site) (HYPH -) (VBN directed)) (NN mutagenesis)))) (CC and) (VP (VBN verified) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN sequence) (NNS data)) (PP (IN of) (NP (ADJP (NN PCR) (HYPH -) (VBN amplified)) (JJ genomic) (NN DNA))) (PP (IN from) (NP (JJ homozygous) (NN mutant) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN F7) (NN mutation)) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG creating) (NP (NP (DT a) (NN targeting) (NN vector)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD incorporated) (NP (NP (DT the) (NML (CD 5) (SYM ′)) (NN arm)) (PP (IN of) (NP (DT the) (NN F5) (NN targeting) (NN vector)))) (PP-MNR (IN with) (NP (NP (NML (CD 5) (SYM ′)) (JJ genomic) (NNS sequences)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD included) (NP (NP (DT the) (NNS exons)) (VP (VBG containing) (NP (DT the) (ADJP (NP (NN Src) (HYPH -) (CC and) (NN Grb2)) (HYPH -) (VBG binding)) (NNS sites)))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Tyrosines) (NML (CD 578) (CC and) (CD 715))) (VP (VBD were) (VP (VBN mutated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN phenylalanine))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB disrupt) (NP (NML (NN Src) (CC and) (NN Grb2)) (NN binding)) (, ,) (ADVP (RB respectively))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN targeting) (NN vector)) (VP (VBD was) (VP (VP (VBN transfected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NN F5) (JJ heterozygous) (NN ES) (NNS cells)))) (CC and) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ homologous) (NN recombination)))))) (. .)) )
( (S (NP-SBJ (DT The) (NN truncation) (NN mutation)) (VP (VBZ possesses) (NP (DT a) (NN frameshift)) (PP-LOC (IN at) (NP (NN amino) (NN acid) (CD 780))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ premature) (NN stop) (NN codon)) (PP-LOC (IN after) (NP (NN amino) (NN acid) (CD 801))) (, ,) (ADVP-LOC (NP (CD 11) (NN amino) (NNS acids)) (RB downstream) (PP (IN of) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NML (NN ES) (NN cell)) (NNS colonies)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (ADVP-TMP (RB initially)) (PP-MNR (IN by) (NP (NN PCR)))))) (, ,) (CC and) (S (NP-SBJ-2 (JJ positive) (NNS clones)) (VP (VBD were) (ADVP (RB further)) (VP (VBN verified) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NNP Southern) (NN blot)) (NN analysis))) (PP-PRP (IN for) (NP (NP (DT the) (JJ correct) (NN recombination)) (PP-LOC (IN at) (NP (DT the) (NML (NML (CD 5) (SYM ′)) (CC and) (NML (CD 3) (SYM ′))) (NNS arms)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN PGK) (HYPH –) (NN neo)) (NNS cassettes)) (VP (VBD were) (VP (VBN removed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (NNS mice)) (PP (IN to) (NP (NML (NML (NN Meox2Cre) (CIT (-LRB- -LRB-) (NNP Tallquist) (CC and) (NNP Soriano) (CD 2000) (-RRB- -RRB-))) (CC and) (NML (NN ROSA26FlpeR) (CIT (-LRB- -LRB-) (NNP Farley) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-)))) (NNS deleters)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN majority)) (PP (IN of) (NP (NNS analyses)))) (VP (VBP have) (VP (VBN been) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN on) (NP (DT a) (VBN mixed) (NML (NML (NN 129S4)) (SYM ×) (NML (NN C57BL) (HYPH /) (CD 6))) (NN background))) (, ,) (PP (IN except) (SBAR-NOM (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN indicated) (NP-2 (-NONE- *)) (ADVP-LOC-3 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN XlacZ4) (JJ transgenic) (NN mouse) (CIT (-LRB- -LRB-) (NNP Tidhar) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (VP (VBD was) (VP (ADVP (RB kindly)) (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP Moshe) (NNP Shani)))) (CC and) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN into) (NP (DT the) (NN F) (NN series))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD crossed) (NP (DT the) (NML (NML (NN F5)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS mice)) (PP (IN to) (NP (DT the) (NN PDGFRαGFP) (NN line))) (CIT (-LRB- -LRB-) (NNP Hamilton) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (NN Histology)) (, ,) (NP (NN Immunohistochemistry)) (, ,) (CC and) (NP (NN Pericyte) (NN Quantitation)))) )
( (S (NP-SBJ-1 (NNS Embryos) (CC and) (NNS tissues)) (VP (VBD were) (VP (VBN processed) (CC and) (VBN embedded) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (VBG sectioning))) (PP-MNR (VBG according) (PP (IN to) (NP (JJ standard) (NN protocol)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (RB not) (VP (VBN examined) (NP (NP (DT the) (NN vasculature)) (PP (IN of) (NP (DT all) (ADJP (NN PDGFRβ) (HYPH -) (VBN dependent)) (NNS tissues)))) (PP-LOC (IN in) (NP (DT the) (NML (NN F) (NN series)) (NN mutant) (NNS animals))))) (. .)) )
( (S (NP-SBJ (NP (DT Those) (NNS tissues)) (VP (RB not) (VBN examined) (NP (-NONE- *)))) (VP (VBP are) (NP-PRD (NP (NN lung)) (, ,) (NP (JJ brown) (NN adipose) (NN tissue)) (, ,) (CC and) (NP (DT the) (JJ adrenal) (NN gland)))) (. .)) )
( (HEADING (NP (NN Immunohistochemistry))) )
( (S (S (NP-SBJ-1 (NNS Kidneys)) (VP (VBD were) (VP (VBN removed) (CC and) (VBN fixed) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 20) (NN min))) (PP (IN in) (NP (NML (CD 4) (NN %)) (NN paraformaldehyde)))))) (, ,) (S (NP-SBJ-2 (NML (CD 200) (NN μm)) (NNS sections)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN obtained) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NN vibratome) (NN sectioning)))))) (, ,) (CC and) (S (NP-SBJ-3 (NN immunofluorescence)) (VP (VBD was) (VP (VBN performed) (NP-3 (-NONE- *))))) (. .)) )
( (S (PP-PRP (IN For) (NP (NN eye) (NN immunohistochemistry))) (, ,) (NP-SBJ-1 (DT the) (VBN pigmented) (NN epithelium)) (VP (VBD was) (VP (VP (VBN removed) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN mouse) (NNS retinas)))) (CC and) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 10) (NN min))) (PP (IN in) (NP (NML (CD 4) (NN %)) (NN paraformaldehyde)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Retinas)) (CC and) (NP (NN kidney) (NNS slices))) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN blocked) (NP-1 (-NONE- *))) (CC and) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NN immunohistochemistry)) (PP (IN for) (NP (DT the) (JJ indicated) (NML (NN v) (HYPH /) (NN p)) (NN marker)))))))) (. .)) )
( (S (NP-SBJ (NNS Antibodies)) (VP (VBD were) (NP-PRD (NP (NN β) (HYPH -) (NN galactosidase) (PRN (-LRB- -LRB-) (NP (CD 55976)) (: ;) (NP (NP (NNP Cappel)) (, ,) (NP-LOC (NNP Costa) (NNP Mesa)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (, ,) (NP (NN αSMA) (PRN (-LRB- -LRB-) (NP (NN 1A4)) (: ;) (NP (NP (NNP Sigma)) (, ,) (NP-LOC (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP Missouri)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN desmin) (PRN (-LRB- -LRB-) (NP (NN D33)) (: ;) (NP (NP (NNP Dako) (NNP Cytomation)) (, ,) (NP-LOC (NNP Glostrup)) (, ,) (NP-LOC (NNP Denmark))) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (NNS Photographs)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (DT a) (NML (NNP Zeiss) (NNP Axiophot)) (NN microscope) (PRN (-LRB- -LRB-) (NP (NP (NML (NNP Carl) (NNP Zeiss)) (NNP MicroImaging)) (, ,) (NP-LOC (NNP Thornwood)) (, ,) (NP-LOC (NNP New) (NNP York)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Pericyte) (NN quantitation))) )
( (S (NP-SBJ-1 (NN E14.5) (NNS embryos)) (VP (VBD were) (VP (VBN divided) (NP-1 (-NONE- *)) (PP (IN into) (NP (NNS quarters))) (PP-LOC (IN at) (NP (NP (DT the) (VBG following) (NNS levels)) (: :) (NP (NP (NP (NN head)) (PP (SYM –) (NP (NN neck)))) (, ,) (NP (NP (NN neck)) (PP (SYM –) (NP (NN liver)))) (, ,) (NP (NP (NN liver)) (PP (SYM –) (NP (NN kidney)))) (, ,) (CC and) (NP (NP (NN kidney)) (PP (SYM –) (NP (NN tail))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Quarters)) (VP (VBD were) (VP (VP (VBN rinsed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN PBS)))) (CC and) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 20) (NN min))) (PP (IN in) (NP (NP (NML (CD 2) (NN %)) (NN formaldehyde)) (, ,) (NP (NML (CD 0.2) (NN %)) (NN glutaraldehyde))))))) (. .)) )
( (S (NP-SBJ-1 (PRP They)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (CD three) (NNS times)) (PP (IN in) (NP (NN PBS)))) (, ,) (VP (VBD stained) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP-MNR (IN with) (NP (NNP X) (HYPH -) (NNP Gal)))) (, ,) (VP (VBN transferred) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN PBS)))) (, ,) (VP (VBN photographed) (NP-1 (-NONE- *))) (, ,) (VP (VBN post-fixed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 10) (NN %)) (NN formalin)))) (, ,) (CC and) (VP (ADVP-TMP (RB then)) (VBN processed) (CC and) (VBN embedded) (NP-1 (-NONE- *))))) (. .)) )
( (S (S (S (NP-SBJ-1=4 (NNS Sections) (PRN (-LRB- -LRB-) (NP (CD 7) (NN μm)) (-RRB- -RRB-))) (VP (VBD were) (VP=3 (VBN generated) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2=4 (ADJP (NP (NNP X) (HYPH -) (NNP Gal)) (HYPH -) (JJ positive)) (NNS nuclei)) (VP=3 (VBN quantitated) (NP-2 (-NONE- *))))) (PP-LOC (IN in) (NP (DT the) (JJ neural) (NN tube))) (PP-LOC (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (DT the) (NN heart)) (CC and) (NP (DT the) (NN kidney)))))) (. .)) )
( (S (S (NP-SBJ-1 (QP (CD Seven) (IN to) (CD ten)) (NNS samples)) (VP (VBD were) (VP (VBN counted) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT each) (NN level)))))) (: ;) (S (NP-SBJ-2 (NP (DT the) (NN mean)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBZ is) (VP (VBN represented) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN Figure) (CD 6)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Pericytes)) (VP (VBG surrounding) (NP (NP (DT the) (NN exterior)) (PP (IN of) (NP (DT the) (JJ neural) (NN tube)))))) (VP (VBD were) (VP (VBN excluded) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN sample))))) (. .)) )
( (S (NP-SBJ-1 (JJ Positive) (NNS nuclei)) (VP (VBD were) (VP (VP (VP (VBN counted) (NP-1 (-NONE- *)) (PP-MNR (IN at) (NP (QP (CD 20) (SYM ×)) (NN magnification)))) (CC and) (VP (VBN photographed) (NP-1 (-NONE- *)) (PP-MNR (IN at) (NP (QP (CD 10) (SYM ×)) (NN magnification))))) (PP-MNR (IN on) (NP (NML (NNP Zeiss) (NNP Axiophot)) (NNS microscopes))))) (. .)) )
( (S (NP-SBJ-1 (NNS Retinas)) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (DT a) (JJ similar) (NN manner))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (VBN pigmented) (NN epithelium)) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *)) (PP-TMP (RB prior) (PP (IN to) (NP (DT the) (JJ initial) (NN fixation) (NN step))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NN lens)) (VP (VBD was) (RB not) (VP (VBN removed) (NP-2 (-NONE- *)) (PP-TMP (IN until) (PP (IN after) (NP (DT the) (JJ final) (NN fixation)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (NN retina) (NN shape)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Images)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (DT a) (NNP Nikon) (NN SMZ1000))) (PP-MNR (IN with) (NP (DT a) (NML (NN Coolpix) (CD 900)) (NN camera))) (PRN (-LRB- -LRB-) (NP (NP (NNP Nikon) (NNP Corporation)) (, ,) (NP-LOC (NNP Tokyo)) (, ,) (NP-LOC (NNP Japan))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NP (NN Immunoprecipitation)) (CC and) (NP (NNP Western) (VBG Blotting)))) )
( (S (NP-SBJ-1 (NNS MEFs)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP (IN from) (NP (ADJP (ADJP (NP (NN E9) (HYPH -) (NN d)) (HYPH -) (JJ old)) (CC or) (ADJP (NP (NN E14.5) (HYPH -) (NN d)) (HYPH -) (JJ old))) (NNS embryos))))) (. .)) )
( (S (NP-SBJ-1 (NNS Embryos)) (VP (VBD were) (VP (VBN isolated) (, ,) (VBN decapitated) (, ,) (CC and) (VBN eviscerated) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBG remaining) (NN tissue)) (VP (VBD was) (ADVP-TMP (RB then)) (VP (VP (VBN treated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN trypsin)))) (CC and) (VP (VBN plated) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NNS Cells)) (VP (VBD were) (VP (VBN frozen) (NP-1 (-NONE- *)) (PRT (RP down)) (PP (IN at) (NP (NNS passages) (NML (CD 2) (CC and) (CD 3)))))) (. .)) )
( (S (NP-SBJ-1 (JJS Most) (NNS experiments)) (VP (VBD were) (VP (VBN completed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NNS cells))) (PP-LOC (IN at) (NP (NNS passages) (CD 3) (SYM –) (CD 6))) (, ,) (PP (IN except) (PP (IN for) (NP (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NN line)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (ADVP (RB spontaneously)) (VP (VBN immortalized) (NP-2 (-NONE- *))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Cells)) (VP (VBD were) (VP (VP (VBN plated) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (QP (QP (CD 1) (SYM ×) (CD 105)) (IN to) (QP (CD 3) (SYM ×) (CD 105))) (NNS cells)) (PP (IN per) (NP (NN well)))))) (CC and) (VP (VBN starved) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 48) (NN h)))))) (. .)) )
( (S (NP-SBJ-1 (NN Receptor) (NN downregulation)) (VP (VBD was) (VP (VBN achieved) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG treating) (NP (JJ starved) (NNS cells)) (PP-TMP (IN for) (NP (CD 2) (NN h))) (PP-MNR (IN with) (NP (NML (NML (CD 100) (NNS ng)) (PP (SYM /) (NP (NN ml)))) (NN PDGFAA))) (PRN (-LRB- -LRB-) (NP (NN R) (CC &) (NN D)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Cells)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN stimulated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN PDGFBB))) (PRN (-LRB- -LRB-) (NP (NN R) (CC &) (NN D)) (-RRB- -RRB-)) (PP-TMP (IN for) (NP (CD 5) (NN min)))) (CC and) (VP (VBN lysed) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Immunoprecipitation)) (CC and) (NP (NNP Western) (VBG blotting))) (VP (VBD were) (VP (VBN executed) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (CIT (-LRB- -LRB-) (NNP Tallquist) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NNS Antibodies)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (JJ following) (NNS sources)) (: :) (NP (NP (NN PDGFRβ) (PRN (-LRB- -LRB-) (NP (CD 06) (HYPH -) (CD 498)) (: ;) (NP (NP (NNP Upstate) (NNP Biotechnology)) (, ,) (NP-LOC (NNP Lake) (NNP Placid)) (, ,) (NP-LOC (NNP New) (NNP York)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (: ;) (NP (NN PDGFRα) (PRN (-LRB- -LRB-) (NP (NN sc) (HYPH -) (NN 338)) (: ;) (NP (NP (NML (NNP Santa) (NNP Cruz)) (NNP Biotechnology)) (, ,) (NP-LOC (NNP Santa) (NNP Cruz)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (: ;) (NP (NN Akt) (PRN (-LRB- -LRB-) (NP (CD 9272)) (: ;) (NP (NP (NML (NNP Cell) (NNP Signaling)) (NNP Technology)) (, ,) (NP-LOC (NNP Beverly)) (, ,) (NP-LOC (NNP Massachusetts)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (: ;) (NP (NN Phospho) (HYPH -) (NN AKT) (PRN (-LRB- -LRB-) (NP (CD 9271)) (: ;) (NP (NML (NNP Cell) (NNP Signaling)) (NNP Technology)) (-RRB- -RRB-))) (: ;) (NP (NN RasGAP) (PRN (-LRB- -LRB-) (NP (CD 05) (HYPH -) (CD 178)) (: ;) (NP (NNP Upstate) (NNP Biotechnology)) (-RRB- -RRB-))) (: ;) (NP (NN Grb2) (PRN (-LRB- -LRB-) (NP (CD 610111)) (: ;) (NP (NP (NN BD) (NNP Transduction) (NNP Laboratories)) (, ,) (NP-LOC (NNP San) (NNP Jose)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (: ;) (NP (NN ERK1) (HYPH /) (CD 2) (PRN (-LRB- -LRB-) (NP (CD 06) (HYPH -) (CD 182)) (: ;) (NP (NNP Upstate) (NNP Biotechnology)) (-RRB- -RRB-))) (: ;) (NP (NN c) (HYPH -) (NN Src) (PRN (-LRB- -LRB-) (NP (NP (NN SRC2)) (CC and) (NP (NN sc) (HYPH -) (NN 18))) (: ;) (NP (NML (NNP Santa) (NNP Cruz)) (NNP Biotechnology)) (-RRB- -RRB-))) (: ;) (NP (NN Phospho) (HYPH -) (NN Src) (NN Y418) (PRN (-LRB- -LRB-) (NP (CD 44) (HYPH -) (CD 660)) (: ;) (NP (NP (NNP Biosource) (NNP International)) (, ,) (NP-LOC (NNP Camarillo)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (: ;) (NP (NN Phospho) (HYPH -) (NN ERK1) (HYPH /) (CD 2) (PRN (-LRB- -LRB-) (NP (CD 9101)) (: ;) (NP (NML (NNP Cell) (NNP Signaling)) (NNP Technology)) (-RRB- -RRB-))) (: ;) (NP (NN PLCγ) (PRN (-LRB- -LRB-) (NP (CD 05) (HYPH -) (CD 163)) (: ;) (NP (NNP Upstate) (NNP Biotechnology)) (-RRB- -RRB-))) (: ;) (NP (NN SHP) (HYPH -) (CD 2) (PRN (-LRB- -LRB-) (NP (NN sc) (HYPH -) (NN 280)) (: ;) (NP (NML (NNP Santa) (NNP Cruz)) (NNP Biotechnology)) (-RRB- -RRB-))) (: ;) (CC and) (NP (NN phosphotyrosine) (PRN (-LRB- -LRB-) (NN 4G10) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD 05) (HYPH -) (CD 321)) (: ;) (NP (NNP Upstate) (NNP Biotechnology)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NN PDGFRβ) (CD 97A) (PRN (-LRB- -LRB-) (NP (NN kinase) (NN insert) (NN domain)) (-RRB- -RRB-))) (VP (VBD was) (NP-PRD (NP (DT a) (JJ kind) (NN gift)) (PP (IN from) (NP (NNP Andrius) (NNP Kazlauskas))))) (. .)) )
( (HEADING (NP (VBG Supporting) (NN Information))) )
( (HEADING (NP (NN Accession) (NNS Numbers))) )
( (S (NP-SBJ (NP (DT The) (NNP LocusLink) (NN ID) (NNS numbers)) (VP (VBN discussed) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN paper))))) (VP (VBP are) (NP-PRD (NP (NN PDGFRα) (PRN (-LRB- -LRB-) (NP (NN Locus) (NN ID) (CD 18595)) (-RRB- -RRB-))) (CC and) (NP (NN PDGFRβ) (PRN (-LRB- -LRB-) (NP (NN Locus) (NN ID) (CD 18596)) (-RRB- -RRB-))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP thank) (NP=1 (NNP Moshe) (NNP Shani)) (PP-PRP=2 (IN for) (NP (DT the) (NN XlacZ4) (JJ transgenic) (NN line)))) (: ;) (VP (NP=1 (NNP Andrius) (NNP Kazlauskas)) (PP-PRP=2 (IN for) (NP (NNS antibodies)))) (: ;) (VP (NP=1 (NP (NNP Elizabeth) (NNP Behler)) (, ,) (NP (NNP Philip) (NNP Corrin)) (, ,) (NP (NNP Triston) (NNP Dougall)) (, ,) (NP (NNP Jason) (NNP Frazier)) (, ,) (CC and) (NP (NNP Tara) (NNP Swamy))) (PP-PRP=2 (IN for) (NP (JJ excellent) (JJ technical) (NN support)))) (: ;) (CC and) (VP (NP=1 (PRP$ our) (NN laboratory) (NNS colleagues)) (PP-PRP=2 (IN for) (NP (NP (NP (NNS discussions)) (CC and) (NP (JJ critical) (NNS comments))) (PP (IN on) (NP (DT the) (NN manuscript))))))) (. .)) )
( (S (NP-SBJ-1 (NNP MDT)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (IN by) (NP-LGS (NP (DT a) (NN fellowship)) (PP (IN from) (NP (DT the) (NNP American) (NNP Cancer) (NNP Society))) (PRN (-LRB- -LRB-) (NP (NN PF) (HYPH -) (NN 98) (HYPH –) (NN 149) (HYPH -) (NN 01)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (PP (IN by) (NP-LGS (NP (NP (NP (NN research) (NN grant) (CD 0330351N)) (PP (IN from) (NP (DT the) (NNP American) (NNP Heart) (NNP Association)))) (CC and) (NP (NP (NN grant) (CD 5) (HYPH -) (NN FY03) (HYPH –) (CD 14)) (PP (IN from) (NP (DT the) (NML (NML (NNP March)) (PP (IN of) (NP (NNP Dime)))) (NML (NNP Birth) (NNPS Defects)) (NNP Foundation))))) (PP (IN to) (NP (NNP MDT))))) (CC and) (PP (IN by) (NP-LGS (NP (NNS grants) (NML (NN HD24875) (CC and) (NN HD25326))) (PP (IN from) (NP (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NP (NNP Child) (NNP Health)) (CC and) (NP (NNP Human) (NNP Development)))))) (PP (IN to) (NP (NNP PS)))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN ERK)) (: -) (NP (JJ extracellular) (ADJP (NN signal) (HYPH -) (VBN related)) (NN kinase))) )
( (NP (NP (NN ES)) (: -) (NP (JJ embryonic) (NN stem))) )
( (NP (NP (NN GFP)) (: -) (NP (JJ green) (JJ fluorescent) (NN protein))) )
( (NP (NP (NN MAP) (NN kinase)) (: -) (NP (ADJP (NN mitogen) (HYPH -) (VBN activated)) (NN protein) (NN kinase))) )
( (NP (NP (NN MEF)) (: -) (NP (NN mouse) (JJ embryonic) (NN fibroblast))) )
( (NP (NP (NN PDGF)) (: -) (NP (ADJP (NN platelet) (HYPH -) (VBN derived)) (NN growth) (NN factor))) )
( (NP (NP (NN PDGFR)) (: -) (NP (NML (ADJP (NN platelet) (HYPH -) (VBN derived)) (NN growth) (NN factor)) (NN receptor))) )
( (NP (NP (NN PI3K)) (: -) (NP (NML (NN phosphatidylinositol) (CD 3) (SYM ′)) (HYPH -) (NN kinase))) )
( (NP (NP (NN PLCγ)) (: -) (NP (NN phospholipase) (NN Cγ))) )
( (NP (NP (NN RTK)) (: -) (NP (NN receptor) (NN tyrosine) (NN kinase))) )
( (NP (NP (NN SFK)) (: -) (NP (NML (NN Src) (NN family)) (NN kinase))) )
( (NP (NP (NN SH2) (NN domain)) (: -) (NP (NML (NN Src) (NN homology)) (NN domain) (CD 2))) )
( (NP (NP (NN SHP) (HYPH -) (NN 2)) (: -) (NP (ADJP (NN SH2) (HYPH -) (VBG containing)) (NN phosphotyrosine) (NN phosphatase))) )
( (NP (NP (NN αSMA)) (: -) (NP (NML (JJ smooth) (NN muscle)) (NN actin) (NN α))) )
( (NP (NP (NN STAT)) (: -) (NP (NP (NN signal) (NN transducer)) (CC and) (NP (NP (NN activator)) (PP (IN of) (NP (NN transcription)))))) )
( (NP (NP (NN v) (HYPH /) (NN p)) (: -) (NP (NP (NML (JJ vascular) (JJ smooth) (NN muscle)) (NN cell)) (HYPH /) (NP (NN pericyte)))) )
( (NP (NP (NN VSMC)) (: -) (NP (NML (JJ vascular) (JJ smooth) (NN muscle)) (NN cell))) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NN PDGFRβ) (JJ Allelic) (NN Series))) )
( (CAPTION (S (NP-SBJ (DT This) (NN figure)) (VP (VBZ depicts) (NP (NP (DT the) (NN mutant) (NNS alleles)) (VP (VBN generated) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN mouse) (NN PDGFRβ) (JJ genomic) (NN locus)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN X)) (VP (VBZ represents) (NP (NP (DT a) (NN mutation)) (PP-LOC (IN in) (NP (NP (DT the) (ADJP (NN tyrosine) (HYPH -) (VBG binding)) (NN site) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP (IN for) (NP (DT a) (JJ particular) (NML (NN signal) (NN transduction)) (NN molecule))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN F7) (NN allele)) (VP (VBZ contains) (NP (DT a) (NN disruption)) (PP-LOC (IN in) (NP (CD one) (ADJP (NN SFK) (HYPH -) (VBG binding)) (NN site))) (SBAR-PRP (IN because) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT both) (NNS sites)))) (VP (VBZ results) (PP (IN in) (NP (VBN diminished) (NN kinase) (NN activity)))))) (CIT (-LRB- -LRB-) (NNP Mori) (FW et) (FW al.) (CD 1993) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN truncation) (NN allele)) (-LRB- -LRB-) (NP (NN βT))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NP (NN deletion)) (CC and) (NP (JJ subsequent) (NN frameshift))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ results) (PP (IN in) (NP (DT a) (NN stop) (NN codon))) (PP-LOC (NP-ADV (CD 32) (NN amino) (NNS acids)) (IN past) (NP (DT the) (ADJP (NN RasGAP) (HYPH -) (VBG binding)) (NN site)))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NN Targeting) (NN Strategy)) (CC and) (NP (NNP Southern) (NN Blot)))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (VBG Targeting) (NN vector)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NN F5) (NN mutant) (NN allele)))))) (. .))) )
( (CAPTION (S (NP-SBJ (CD Two) (NNS exons)) (VP (VBP contain) (NP (DT all) (CD five) (JJ mutated) (NNS tyrosines))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (VBG Targeting) (NN vector)) (VP (VBG containing) (NP (NNS mutations)) (PP-LOC (IN in) (NP (NP (NML (CD 5) (SYM ′)) (NNS exons)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (DT the) (NN F7) (NN mutant) (NN allele))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NML (JJ Wild) (HYPH -) (NN type)) (NN allele) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (VBD Targeted) (NN allele)) (PP (IN with) (NP (NML (NN PGK) (HYPH –) (NN neo)) (NN removal))) (. .))) )
( (CAPTION (NP (NP (NML (NN Restriction) (NN enzyme)) (NNS abbreviations)) (: :) (NP (NP (NP (NN Sp)) (, ,) (NP (NN SpeI))) (: ;) (NP (NP (NN A)) (, ,) (NP (NN Asp718))) (: ;) (NP (NP (NN S)) (, ,) (NP (NN SacI))) (: ;) (NP (NP (NN RV)) (, ,) (NP (NN EcoRV))) (: ;) (NP (NP (NN H)) (, ,) (NP (NN HindIII))) (: ;) (NP (NP (NN X)) (, ,) (NP (NN XhoI))) (: ;) (CC and) (NP (NP (NN RI)) (, ,) (NP (NN EcoRI)))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Green) (NNS boxes)) (VP (VBP indicate) (NP (NP (NNS probes)) (VP (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (NNP Southern) (VBG blotting))) (PP (IN for) (NP (ADJP (NN F7) (HYPH -) (VBN targeted)) (NN ES) (NNS cells)))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ blue) (NN arrow)) (VP (VBZ indicates) (NP (NP (DT the) (NN exon)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NN point) (NN mutation)) (VP (VBZ causes) (NP (NN frameshift)) (PP (IN in) (NP (NN truncation) (NN mutation))) (ADVP-1 (-NONE- *T*))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Black) (NNS boxes)) (VP (VBP indicate) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS exons))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Red) (NNS boxes)) (VP (VBP indicate) (NP (NP (NNS exons)) (VP (VBG containing) (NP (VBN targeted) (NNS mutations))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Restriction) (NNS enzymes)) (PP (IN in) (NP (JJ red)))) (VP (VBP indicate) (NP (NP (NNS sites)) (VP (VBN introduced) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NN mutagenesis))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB verify) (NP (JJ proper) (JJ homologous) (NN recombination)) (PP-MNR (IN by) (NP (NNP Southern) (VBG blotting))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Circles)) (VP (VBP denote) (NP (NN FRT) (NNS sites))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Triangles)) (VP (VBP denote) (NP (NN loxP) (NNS sites))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NML (NNP Southern) (NN blot)) (NNS results)) (PP (IN from) (NP (JJ various) (NN ES) (NN cell) (NNS lines))) (. .))) )
( (CAPTION (NP (NP (NN SpeI) (NN digest)) (VP (VBG using) (NP (NN P1) (NN probe))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Blot)) (PP (IN with) (NP (NN P2) (NN probe)))) (VP (VBD gave) (NP (VBN expected) (NNS results)) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (FRAG (NP (NNS Lanes) (NML (CD 1) (CC and) (CD 3))) (, ,) (FRAG (NP (NN F5) (NN allele)) (VP (VBN targeted) (NP (-NONE- *)))) (. .))) )
( (CAPTION (FRAG (NP (NNS Lanes) (NML (CD 2) (CC and) (CD 4))) (, ,) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (NN allele)) (VP (VBN targeted) (NP (-NONE- *)))) (. .))) )
( (CAPTION (FRAG (NP (NNS Lanes) (NML (CD 5) (CC and) (CD 7))) (, ,) (NP (NP (NML (NN F5) (NN mutant)) (NN ES) (NNS cells)) (PP-TMP (PP (IN after) (NP-1 (-NONE- *RNR*))) (CC and) (PP (IN before) (NP-1 (-NONE- *RNR*))) (NP-1 (NN Cre) (NN activity)) (, ,) (ADVP (RB respectively)))) (. .))) )
( (CAPTION (FRAG (NP (NN Lane) (CD 6)) (, ,) (NP (NML (JJ wild) (HYPH -) (NN type)) (NML (NN ES) (NN cell)) (NN clone)) (. .))) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (NN Eye) (NNS Defects)) (PP-LOC (IN in) (NP (NML (NN F5) (HYPH /) (SYM −)) (NNS Mice))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (NNS Eyes)) (PP (IN from) (NP (DT a) (NN P4) (NML (NN F5) (HYPH /) (SYM −)) (NN mouse)))) (VP (VBG demonstrating) (NP (JJ severe) (NN hemorrhaging))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (CC and) (LS C) (-RRB- -RRB-)) (NP (ADJP (NP (NN H) (HYPH /) (NN E)) (HYPH -) (VBN stained)) (JJ sagittal) (NNS sections)) (PP (IN through) (NP (NP (NNS eyes)) (PP (IN of) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN F5) (HYPH /) (SYM −)) (ADJP (NP (CD 3) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (NNS mice)) (, ,) (ADVP (RB respectively)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN absence)) (PP (IN of) (NP (NP (DT the) (NN lens)) (PP (IN of) (NP (DT the) (NML (NN F5) (HYPH /) (SYM −)) (NN eye)))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ histological) (NN defect)) (CONJP (CC and) (RB not)) (NP (NP (DT a) (NN phenotype)) (PP (IN of) (NP (DT the) (NML (NN F5) (HYPH /) (SYM −)) (NN eye)))))) (. .))) )
( (CAPTION (NP (NP (NP (NN L)) (, ,) (NP (NN lens))) (: ;) (NP (NP (NN R)) (, ,) (NP (NN retina))) (. .))) )
( (HEADING (NP (NN Figure) (CD 8))) )
( (HEADING (NP (NP (NML (NN V) (HYPH /) (NN P)) (NNS Populations)) (PP-LOC (IN in) (NP (NN P28) (NNS Retinas))))) )
( (CAPTION (NP (NP (NML (JJ Whole) (HYPH -) (NN mount)) (JJ retinal) (NNS preparations)) (PP (IN from) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN mutant))) (NNS eyes))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Pigmented) (NN epithelium)) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN visualization)) (PP (IN of) (NP (NN β) (HYPH -) (NN galactosidase))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (-NONE- *0*) (S (NP-SBJ (NP (NN F7) (HYPH /) (NN F7)) (CC and) (NP (NN F7) (HYPH /) (SYM −))) (VP (VBD had) (NP (NP (NP (JJ extensive) (NN thickening)) (PP (IN of) (NP (DT the) (JJ retinal) (NNS layers)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (NN contraction)) (PP (IN of) (NP (DT the) (JJ entire) (NN retina)))) (CC and) (NP (NP (JJ apparent) (NN reduction)) (PP (IN in) (NP (NN size)))))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (ADJP (RB far) (JJ right)) (NN panel)) (VP (VBZ shows) (NP (NP (DT a) (NN close) (HYPH -) (NN up)) (PP (IN of) (NP (NP (DT the) (NML (NN artery) (CC and) (NN vein))) (PP (IN of) (NP (CD three) (JJ homozygous) (NNS eyes))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 9))) )
( (HEADING (NP (NP (JJ Vascular) (NML (JJ Smooth) (NN Muscle)) (NNS Cells)) (PP (IN of) (NP (DT the) (JJ Coronary) (NNS Arteries))))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Top)) (-RRB- -RRB-)) (NP (NML (JJ Whole) (HYPH -) (NN mount)) (NNS views)) (PP (IN of) (NP (NP (NN P21) (NNS hearts)) (PP (IN from) (NP (NP (NNS littermates)) (PP (IN of) (NP (NP (DT the) (NN F5) (NNS alleles)) (PP (IN of) (NP (NN mutant) (NNS mice))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NNS Hearts)) (VP (VBD were) (VP (VBN sliced) (NP-1 (-NONE- *)) (ADVP-MNR (RB coronally))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (JJ ventral) (NN surface)) (VP (VBD was) (VP (VBN photographed) (NP-2 (-NONE- *))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NML (NN F5) (HYPH /) (NN −)) (NN heart)) (VP (VP (VBD was) (VP (VBN sliced) (NP-1 (-NONE- *)) (ADVP-MNR (RB disproportionately)))) (CC and) (VP (ADVP (RB therefore)) (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJR smaller))))))) (. .))) )
( (CAPTION (NP (PRN (-LRB- -LRB-) (NP (NN Bottom)) (-RRB- -RRB-)) (NP (NN P28) (NNS hearts)) (PP (IN from) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN F1))) (NNS littermates))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Hearts)) (VP (VBD were) (VP (VBN sliced) (NP-1 (-NONE- *)) (ADVP-MNR (RB sagittally)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (CC Both) (DT the) (ADJP (JJ left) (CC and) (JJ right)) (NNS views)) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Tissue) (NN Localization)) (PP (IN of) (NP (NP (NML (NML (NN V) (HYPH /) (NN P)) (NN Cell)) (NNS Markers)) (CC and) (NP (NN PDGFRα) (NN Expression)))))) )
( (CAPTION (NP (NP (NN Tissue) (NNS preparations)) (PP (IN from) (NP (NP (NN P21) (NN PDGFRαGFP) (HYPH /) (SYM +)) (: ;) (NP (NML (NN PDGFRβF5) (HYPH /) (NN F5)) (NN mutant) (NN mouse)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Immunofluorescence)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB detect) (NP (NP (NP (NN αSMA) (PRN (-LRB- -LRB-) (NP (NN A) (CC and) (NN B)) (-RRB- -RRB-))) (, ,) (NP (NN desmin) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (, ,) (NP (NN β) (HYPH -) (NN galactosidase) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN GFP) (NN expression))) (PP (IN for) (NP (NN PDGFRα) (PRN (-LRB- -LRB-) (NP (NP (NN A)) (PP (SYM –) (NP (NN D)))) (-RRB- -RRB-)))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Kidney) (PRN (-LRB- -LRB-) (NP (NML (CD 200) (NN μm)) (NN vibratome) (NN section)) (-RRB- -RRB-)) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN arrow)) (VP (VBZ indicates) (NP (NN glomerulus))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN asterisk)) (VP (VBZ indicates) (NP (DT an) (NN arteriole))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (SYM –) (LS D) (-RRB- -RRB-)) (NN Retina) (PRN (-LRB- -LRB-) (NP (NML (JJ whole) (HYPH -) (NN mount)) (NN preparation)) (-RRB- -RRB-)) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Arrowheads)) (VP (VBP point) (PP (IN to) (NP (ADJP (NP (NN β) (HYPH -) (NN galactosidase)) (HYPH -) (JJ positive)) (NNS nuclei)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NN Reduction)) (PP (IN in) (NP (NML (NN V) (HYPH /) (NN P)) (NNS Cells))) (PP-LOC (IN in) (NP (NP (DT the) (JJ Thoracic) (NN Region)) (PP (IN of) (NP (NN E14.5) (NNS Embryos))))))) )
( (CAPTION (NP (NP (JJ Ventral) (NN view)) (PP (IN of) (NP (NML (NN E14.5) (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN F7) (HYPH /) (SYM −)))) (NNS littermates))) (PP (IN with) (NP (DT the) (NML (NN XlacZ4) (NN mouse) (NN marker)) (NN background))) (. .))) )
( (CAPTION (S (NP-SBJ (ADJP (NP (NN β) (HYPH -) (NN Galactosidase)) (HYPH -) (JJ positive)) (NNS nuclei)) (VP (VBP represent) (NP (NML (NN v) (HYPH /) (NN p)) (NNS cells))) (. .))) )
( (CAPTION (NP (NP (NN Th)) (, ,) (NP (NN thymus)) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (NP (NP (NNS Pericytes)) (PP-LOC (IN within) (NP (NP (DT the) (NN E14.5) (JJ Nervous) (NN System)) (PP (IN of) (NP (NML (NN F) (NN Series)) (NN Mutant) (NNS Embryos))))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (JJ Representative) (NNS sections)) (PP (IN through) (NP (NP (JJ neural) (NNS tubes)) (PP (IN of) (NP (NP (NNS embryos)) (PP (IN from) (NP (DT the) (JJ homozygous) (NN F) (JJ allelic) (NN series))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (JJ Representative) (NNS sections)) (PP (IN of) (NP (NNS embryos))) (PP (IN from) (NP (NP (DT the) (JJ hemizygous) (JJ allelic) (NN series)) (-LRB- -LRB-) (NP (NP (NML (NN F) (NN series)) (NN mutant)) (PP (IN with) (NP (NP (CD one) (NN copy)) (PP (IN of) (NP (DT the) (JJ null) (NN allele)))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Sections)) (VP (VBP are) (PP-PRD (IN from) (NP (NP (DT the) (JJ rostral) (NN level)) (PP (IN between) (NP (DT the) (NML (NN heart) (CC and) (NN kidney))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Pericytes)) (VP (VBP are) (VP (VBN visualized) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (ADJP (JJ nuclear) (HYPH -) (VBN localized)) (NML (NN β) (HYPH -) (NN galactosidase)) (VBG staining))) (PP-LOC (IN in) (NP (NP (NNS cells)) (VP (VBN committed) (NP (-NONE- *)) (PP (IN to) (NP (DT the) (NML (NN v) (HYPH /) (NN p)) (NN lineage)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Sections)) (VP (VBP are) (NP-PRD (CD 7) (NNS μm))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (NP (NP (NN Quantitation)) (PP (IN of) (NP (NNS Pericytes))) (PP-LOC (IN in) (NP (JJ Nervous) (NN System))))) )
( (CAPTION (S (NP-SBJ-1 (ADJP (NP (NN β) (HYPH -) (NN Galactosidase)) (HYPH -) (JJ positive)) (NNS nuclei)) (VP (VBD were) (VP (VBN counted) (NP-1 (-NONE- *)) (PP-LOC (IN within) (NP (DT the) (JJ neural) (NN tube))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT Each) (NN datapoint)) (VP (VBZ represents) (NP (NP (DT a) (NN mean)) (PP (IN of) (NP (NP (QP (CD seven) (IN to) (CD ten)) (NNS sections)) (PP (IN from) (NP (DT a) (JJ single) (NN embryo))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN gathered) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (CD two) (JJ rostral) (NNS levels))) (PP-LOC (IN in) (NP (DT each) (NN embryo))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NNS genotypes)) (VP (VBP are) (VP (VBN ordered) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (VBN predicted) (NN strength)) (PP (IN of) (NP (DT the) (NN signal))))) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS copies)) (PP (IN of) (NP (DT the) (NN receptor)))))) (VP (VBG being) (VP (VBN expressed) (NP (-NONE- *))))) (CC and) (NP (NP (DT the) (NN signal) (NN transduction) (NNS pathways)) (VP (VBG remaining) (ADVP-LOC (RB downstream) (PP (IN of) (NP (DT the) (NN receptor))))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT A) (ADJP (CD two) (HYPH -) (VBN tailed)) (NP (NNP Student) (POS 's)) (NN t) (HYPH -) (NN test)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NML (JJ spinal) (NN cord)) (NNS perictyes)) (PP-LOC (IN in) (NP (NNS mutants)))))) (PP (IN to) (NP (NP (DT those)) (PP-LOC (IN in) (NP (JJ wild) (HYPH -) (NN type)))))))))) (, ,) (CC and) (S (NP-SBJ (DT all) (NML (NML (JJ homozygous) (NNS mutants)) (CC and) (NML (NML (JJ hemizygous) (NN mutant)) (NNS values)))) (VP (VBD were) (ADJP-PRD (RB statistically) (JJ different) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.005)))) (-RRB- -RRB-)) (PP (IN from) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS values)))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN F1) (HYPH /) (SYM −)) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (RB statistically) (JJ different) (PP (IN from) (NP (DT the) (NN PDGFRβ+) (HYPH /) (SYM −) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 10))) )
( (HEADING (NP (NP (NN Biochemistry)) (PP (IN of) (NP (NP (NNS MEFs)) (PP (IN from) (NP (NML (NN F7) (CC and) (NN F1)) (NNS Mice))))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-2 (NML (JJ Whole) (HYPH -) (NN cell)) (NNS lysates)) (VP (VBD were) (VP (VBN generated) (NP-2 (-NONE- *)) (PP (IN from) (NP (NP (NNS MEFs)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (UCP-PRD (ADJP (JJ unstimulated)) (CC or) (VP (VBN stimulated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN PDGFAA) (CONJP (CC and) (HYPH /) (CC or)) (NN PDGFBB)) (ADVP (RB alone)))) (, ,) (NP-ADV (NP (NP (NP (CD 100) (NNS ng)) (PP (SYM /) (NP (NN ml)))) (CC and) (NP (NP (CD 30) (NNS ng)) (PP (SYM /) (NP (NN ml))))) (, ,) (ADVP (RB respectively)))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Lysates)) (VP (VBD were) (ADVP (RB then)) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NP (NN SDS) (HYPH –) (NN PAGE)) (CC and) (NP (NNP Western) (VBG blotting))) (VP (VBN accomplished) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT the) (NN anti-phosphotyrosine) (NN antibody)) (-LRB- -LRB-) (NP (NN 4G10))))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Immunoprecipitation)) (PP (IN of) (NP (NP (ADJP (NN tyrosine) (HYPH -) (VBN phosphorylated)) (NN proteins)) (PP (IN from) (NP (NP (JJ wild) (HYPH -) (NN type)) (CC and) (NP (NP (DT the) (NN F7) (NN series)) (PP (IN of) (NP (NN mutant) (NNS MEFs)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT The) (NNS precipitates)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN run) (NP-1 (-NONE- *)) (PP (IN on) (NP (NN SDS) (HYPH –) (NN PAGE)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT a) (NNP Western) (NN blot)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (JJ anti-Src) (PRN (-LRB- [) (NP (NN pY418)) (-RRB- ])) (NN antibody)) (CC and) (NP (NN anti-PDGFRβ) (CD 97A)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NML (JJ Whole) (HYPH -) (NN cell)) (NNS lysates)) (PP (IN from) (NP (ADJP (JJ unstimulated) (CC or) (JJ stimulated)) (NNS MEFs))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Lysates)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NP (NNP SDS) (HYPH –) (NNP PAGE)) (CC and) (NP (NNP Western) (VBG blotting))) (VP (VBN accomplished) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (JJ indicated) (ADJP (VBN phosphorylated) (HYPH -) (JJ specific)) (NNS antibodies)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (VP (VP (VP (VBN stripped) (NP-1 (-NONE- *))) (CC and) (VP (VBN blotted) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (PP (IN to) (NP (DT the) (VBG corresponding) (JJ unphosphorylated) (NN proteins))))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB demonstrate) (NP (NN protein) (NN loading))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Data)) (VP (VBP are) (ADJP-PRD (JJ representative) (PP (IN of) (NP (NP (JJ multiple) (NNS experiments)) (PP (IN from) (NP (QP (RB at) (RBS least) (CD two)) (ADJP (RB independently) (VBN derived)) (NN cell) (NNS lines))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NP (NNP Western) (NNS blots)) (PP (IN of) (NP (NML (JJ whole) (HYPH -) (NN cell)) (NNS lysates))) (PP (IN from) (NP (NP (QP (CD 5) (SYM ×) (NN 104)) (NNS cells)) (PP (IN per) (NP (NN lane)))))) (VP (VBN blotted) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNS antibodies)) (PP (IN to) (NP (NP (NN PDGFRβ) (PRN (-LRB- -LRB-) (NP (CD 06) (HYPH -) (CD 498)) (-RRB- -RRB-))) (CC and) (NP (NN ERK)))))) (PP-PRP (IN as) (NP (DT a) (NN loading) (NN control)))) (. .))) )
( (HEADING (NP (NNS Footnotes))) )
( (HEADING (NP (NP (NNS Conflicts)) (PP (IN of) (NP (NN Interest))) (. .))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (NP (DT no) (NNS conflicts)) (PP (IN of) (NP (NN interest)))) (VP (VBP exist)))))) (. .)) )
( (HEADING (NP (NN Author) (NNS Contributions) (. .))) )
( (S (NP-SBJ (NNP MDT) (CC and) (NNP PS)) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP MDT) (CC and) (NNP WJF)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP MDT)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP MDT)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (NP (NP (JJ Academic) (NN Editor)) (: :) (NP (NP (NNP Roel) (NNP Nusse)) (, ,) (NP-LOC (NP (NNP Stanford) (NNP University) (NNP School)) (PP (IN of) (NP (NNP Medicine)))))) )

